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Abstract
The peroxiredoxins (Prxs) are a ubiquitous family of antioxidant enzymes that regulate 
intracellular levels of H2O2 where they are implicated in both tissue protection against 
oxidative stress and HiOi-mediated signalling pathways (Wood et al., 2003), This 
thesis describe our results on the structure-function studies of PrxIII, a mitochondrial
typical 2-Cys peroxiredoxin.
Bovine PrxIII was cloned previously in our laboratory; however PrxIII requires its 
cognate partners, mammalian mitochondrial thioredoxin (Trx2) and mammalian 
mitochondrial thioredoxin reductase (TRR2), to reconstitute the complete antioxidant 
defence system. To establish a direct in vitro assay for PrxIII, Trx2 and TRR2 were 
cloned, overexpressed and purified in this study. As TRR2 is a selenocysteine (SeCys) 
protein, a suitable selenocysteine insert sequence (SECIS) for the translation of its 
penultimate SeCys codon was introduced by incorporating it into the reverse primer 
for PCR. A combination of different approaches was used for the successful 
overexpression of active TRR2. Overexpression in modified rich LB media at 15°C in 
the presence of low IPTG concentrations gave good overexpression of soluble enzyme. 
Moreover, the addition of the SECIS at the C-terminal of the insert, in the presence of 
1 p.M Na2 SeÜ3 and co-expression of the SelABC plasmid ensured an optimal supply of 
the relevant tRNA, tRNA synthase and elongation factor for translation of the UGA 
SeCys codon.
Assays showed that NADPPI-linked oxidation needed the presence of all three 
enzymes to reduce H2O2 . PrxIII was also shown to reduce other organic peroxides, 
although with lower activity. Cys47 and Cysl68, but not Cys66, proved to be crucial 
for peroxiredoxin activity. Interestingly, at high H2O2 concentrations in the non- 
physiological range, TRR2 also had the capacity to reduce H2O2 directly in an 
NADPH-dependent manner. PrxIII is also shown to be susceptible to overoxidation 
and loses peroxidase activity at increased H2O2 levels in the range 50p,M to ImM. This
I
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was monitored by SDS-PAGE analysis of partially or fully overoxidised forms of 
H202-mediated PrxIII and PrxIII pathway assays.
Gel filtration chromatography was used to determine under which conditions the PrxIII 
dodecamer would dissociate into dimers. The results show that redox state, protein 
concentration and the N-terminal His-tag all affect the oligomerization of PrxIII.
The crystal structure of the PrxIII C168S mutant from bovine mitochondria has been 
determined at a resolution of 3.3 angstroms. The stmcture reveals that the toroid is 
composed of 12 (not 10) monomers with a 6(2,2) symmetiy. Each ring has an external 
diameter of 150 angstroms and encompasses a central cavity 70 angstroms in width. 
Surprisingly, two PrxIII rings are mechanically interlocked in the crystal to form a 
protein catenane. Interestingly, the catenated form represents only a small proportion 
(3-5%) of the total PrxIII population, as observed by electronic microscopy studies at 
dilute concentration (10-50pg/ml). Preliminary analytical ultracentrifugation data 
suggest that 2-ring catenane formation is concentration dependent. A general model 
illustrating catenane formation arising fi’om polar contacts between two basic dimeric 
units is described. It is not clear whether the catenated form of PrxIII has any 
physiological function. However, the observation that Prxs can protect cells from heat 
shock in a peroxidase-independent process might provide new insights into possible 
novel functions.
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Introduction
1.1 Oxidative stress
Oxidative stress is a term used to describe severe damage to cells, arising from an 
imbalance in the metabolism of redox-active species. The reduction of O2 to H2O 
requires four electrons. If this happens in 2-electron steps, only H2O2 is produced 
as an intermediate. However, O2 has a preference for univalent pathways of 
reduction, resulting in several partially-reduced products of O2 , the so called 
reactive oxygen species (ROS). There are three major ROS generated via O2 
reduction: the superoxide anion (Q2 "), hydrogen peroxide (H2O2) and the hydroxyl 
radical ( ’OH) (Fig. 1.1). When ROS levels exceed the antioxidant capacity of 
cells, oxidative stress results. Both O2 "and ' OH are extremely reactive and can 
cause damage to all the major types of cellular macromolecules, among which the 
unsaturated lipids, proteins and DNA appear most sensitive. Failure to respond to 
damage can lead to abnormalities of function and ultimately cell death.
'Op4
from complexes I and III (Boveris and Chance, 1973; Cadenas et a l, 1977; 
Turrens, 1997). As O2 " is a charged molecule, it cannot cross membranes;
Overall reaction : Og -  40" 4 tF  — 2HgO
Figure 1.1 Pathways in the univalent reduction of oxygen to water leading 
to the formation of various intermediate reactive oxygen species (ROS)
Taken from (Scandalios, 2002)
Mitochondria do not only produce ATP, but they also increase the production of 
ROS as by-products of aerobic metabolism. Most ROS in unstimulated mammalian 
cells are generated as a result of the univalent reduction of molecular oxygen to 
O2 ' by electrons that leak from the mitochondrial electron transport chain, mainly
%
therefore it inhibits mitochondrial function, principally by inactivating the Fe-S 
centres in the electron transport chain (complexes I, II and III) and the tricarboxylic 
acid cycle (aconitase) (Wallace, 1999).
Oxidative stress produces reactive oxygen species that damage DNA and most 
other biological macromolecules. To prevent this kind of damage, living organisms 
have a series of defence systems involving several antioxidant enzymes, such as 
superoxide dismutase (SOD) and catalase, as well as the glutathione and 
thioredoxin systems.
1.2 SOD
SODs are found widely distributed in prokaryotic and eukaryotic cells (Fridovich, 
1995). They are an enzyme family that catalyzes the conversion Qz" to H2O2 . 
Three types of SODs are known in humans. SODl, or CuZn-SOD, was the first 
enzyme to be characterized and is a copper and zinc-containing homodimer that is 
found almost exclusively in intracellular cytoplasmic spaces (McCord and 
Fridovich, 1969). S0D2, or Mn-SOD, exists as a tetramer and is initially 
synthesized containing a leader peptide, which targets this manganese-containing 
enzyme exclusively to the mitochondrial matrix (Chance et a l, 1979). S0D3, or 
EC-SOD is the most recently characterized SOD and exists as a copper and zinc- 
containing tetramer which is synthesized containing a signal peptide that directs 
this enzyme exclusively to extracellular spaces (Marklund et a l, 1982). The rate of 
reaction between superoxide anion and nitric oxide was found to be very fast (2 x 
1 0 ’® M'*s''). Therefore, high levels of SOD are needed to compete for superoxide 
anions when nitric oxide is present. Evidence has accumulated to show that SOD is 
involved in a number of diseases and pathologies such as amyotrophic lateral 
sclerosis (ALS) (Rosen et a l, 1993), Down’s syndrome (Avraham et a l, 1988), and 
premature aging (Rosenblum et a l, 1996). I
However, the SOD reaction only partially relieves oxidative stress in mitochondria, 
since its product, H2O2 , is itself a mild oxidant and is readily converted to the more 
powerful oxidant OH via the Fenton reaction (Fig 1.2). Intracellular H2O2 is 
removed mostly by catalase, glutathione peroxidase (GPx), and the peroxiredoxins
7
(Prxs).
H2O2+ CuVFe^^ > 'OH + OH + CuUpe '^''
Figure 1.2 The Fenton reaction
1.3 Catalase and GPx
Catalase is a liaem-coiitaining enzyme that is located only in peroxisomes and 
breaks down hydrogen peroxide to water and oxygen. It is believed to remove 
H2O2 that passively diffuses into the organelle or to prevent H2O2 leakage (Putnam 
et a l, 2000).
GPx catalyzes the reduction of H2O2 and of various organic hydroperoxides with 
glutathione as the electron donor. There are at least four GPx isoforms in 
mammalian cells. GPxl is the major isoform and is expressed in all tissues; it is 
localized predominantly in the cytosol, but a small proportion (10%) of GPxl 
molecules are also present in the matrix of mitochondria (Panfili et al., 1991; 
Esworthy et a l, 1997; Ho et a l, 1997; Legault et a l, 2000). As catalase is not 
available in mitochondria in most cell types except in rat myocytes (Radi et a l, 
1991), GPxl has been thought to play the major role in the protection of these 
organelles against oxidative damage by reducing H2O2 (Makino et a l, 1994; 
Turrens, 1997; de Haan et a l, 1998; Kokoszka et a l, 2001). However, homozygous 
GPxl knockout mice appear healthy and do not manifest an increased sensitivity to 
hyperoxia or show an increased content of protein carbonyl groups or lipid 
peroxides (Ho et a l, 1997), suggesting that other anti oxidant enzymes are also 
involved in the protection from ROS.
1.4 Peroxiredoxins (Prxs)
The peroxiredoxins (Prxs) are a ubiquitous family of antioxidant enzymes that
regulate intracellular levels of H2O2 where they are implicated in both tissue
.protection against oxidative stress and H202-mediated signalling pathways. In 
recent years, their key role in anti oxidant defence has been emphasised by their
high abundance in both bacterial and mammalian cells. Prxs can be classified as 1- I
Ali the typical 2-Cys Prxs show very similar monomer structures with a
Cys or 2-Cys Prxs based on the number of cysteine residues participating in 
catalysis. There is a further subdivision into two classes called the ‘typical’ and 
‘atypical’ 2-Cys Prxs based on stmctural and mechanistic data. This diverse group 
of antioxidant enzymes is widespread in nature with many organisms producing a 
number of isoforms, leading to a further division into six subclasses (Wood et a l.
2003).
F
.Typical 2-Cys Prxs function as thioredoxin-dependent hydroperoxide reductases 
and are organised as homodimers in which the adjacent subunits interact in a 'head- 
to-tail' fashion. During the catalytic cycle, the N-terminal peroxidatic cysteine is 
oxidised to a cysteine sulphenic acid by its peroxide substrate, which subsequently !
forms an inter-subunit disulphide bond with the conserved C-terminal resolving 
cysteine of its partner (Fig 1.3a). The catalytic cycle of typical 2-Cys Prxs was 
described in a recent review (Wood et a l, 2003). Atypical 2-Cys Prxs exist as 
monomers or dimers and generate an intramolecular disulphide bond during the 
reaction. Crystal stmctures have now been reported for 5 atypical 2-Cys, 8 typical 
2-Cys and 4 1-Cys Prxs (Table 1). In 5 of the typical 2-Cys structures, the basic 
dimeric unit is further assembled into decameric rings. In the remaining 2-Cys and
1-Cys Prxs, the structures are monomers or dimers, with two exceptions. Recently 
an octameric organisation has been reported for a 1-Cys Prx from Mycobacterium 
tuberculosis (Li et a l, 2005) and another 2-Cys Prx from the same organism has 
been shown to exist as a dodecamer (Guimaraes et a l, 2005). As the basic 
functional unit of all Pi"xs is either a monomer or dimer, the precise relationship 
between peroxidase activity and the oligomeric state of these enzymes is unclear.
I
thioredoxin fold, consisting of a seven stranded (3-sheet with parallel and anti- 
parallel alignments. The sheet is suiTounded by four or five a-helices of varying 
length (Fig 1.3b). Typical 2-Cys Prxs form stable homodimers with the two 
subunits arranged in a "head-to-tail” fashion. The dimer interface, which has an 
NCS 2-fold, is created mainly by the formation of an anti-parallel (3-sheet ((37 from 
each monomer), which produces a 14-stranded, twisted p-sheet running through the 
centre of the dimer. f
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a) HOH
2-Cys Prx;^ < — 2- Cys Prx;2 RSH ROM
Disulphidc
reductase
RSSR 2-Cys Prx ROOM
Figure 1.3 Proposed catalytic mechanism and crystal structure o f typical 2-Cys 
peroxiredoxins
a) Peroxidatic cysteines (SpH) and resolving cysteines ( S rH) in their reduced form. In 
the case of dimeric 2-Cys Prxs, the black S? and pink S r from different subunits 
condense to form an intersubunit disulphide bond (black and pink striped bar), b) 
crystal structure of Thioredoxin peroxidase B (TPxB) from red blood cells. Taken 
from (Schroder et al., 2000).
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>DB ID Res Prx type Oligomericstate Year Name
Iprx 2.0A 1-cys 2 1998 Human open reading frame 6 
(hORF6) (Choi et a l,  1998)
Ixcc 2.3A 1-cys 2 2004 1-Cys peroxiredoxin from 
Plasmodium yoelli (To be 
published)
Ixiy 1.8A 1-cys 2 2004 1-Cys peroxiredoxin from 
Plasmodium falciparum (Sarma 
e ta l ,2 m S )
Ixvw 1.9A 1-cys 8 2004 AhpE from Mycobacterium 
tuberculosis (Li et a l,  2005)
lh d 2 1.5A atypical 1 2000 Human Prx5 (Declercq et a l, 
2001)
lnm 3 2.8A atypical 2 2003 Haemophilus influenza Hybrid- 
Prx5 (Kim et a l ,  2003)
Ipsq 2.3A atypical 2 2003 Probable tiiiol peroxidase from 
Streptococcus pneumoniae (To 
be published)
Iqxh 2.2A atypical 2 2003 Thiol peroxidase from 
Escherichia coli (Choi et a l, 
2003)
lq98 1.9A atypical 2 2003 Thiol peroxidase from 
Haemophilus influenzae (To be 
published)
le 2 y 3.2A typical 10 2000 Tryparedoxin peroxidase from 
Crithidia fasciculata (Alphey et 
al,lQQQ)
InSj 2.17A typical 10 2002 Alkyl hydroperoxide reductase 
C (AhpC) C46S (Wood et a l,  
2003)
Iqmv 1.7A typical 10 1999 Thioredoxin peroxidase B 
(TPxB) from red blood cells 
(Sclrroder et a l ,  2000)
lq q 2 2.6A typical 2 1999 Heme-binding protein 23 
(HBP23) (Hirotsu et a l,  1999)
ltp9 1.62A typical 2 2004 Prx D (Type II) from Populus 
tremula (Echalier et a l,  2005)
luul 2.8A typical 10 2003 Tryparedoxin peroxidase from 
Trypanosoma cruzi (Pineyro et 
a/., 2005)
Ivgs 2.31A typical 10 2004 Peroxiredoxin from Aeropyrum 
pernix K1 (Mizohata et a l, 
2005)
IweO 2.9A typical 10 2004 AhpC from Amphibacillus 
xylanus (Kitano et a l,  2005)
2bmx 2.4A typical 12 2005 AhpC from Mycobacterium
tuberculosis (Guimaraes et al., 
2005)
î
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Table 1.1 Peroxiredoxin crystal structures
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1.5 Prx function
Apart from their antioxidant functions, resulting from their ability to regulate levels 
of hydrogen peroxide, Prxs have also been implicated in peroxide-mediated 
signalling cascades (Fujii and Ikeda, 2002). Prxs are associated with diverse 
cellular functions, such as regulation of NF~kB activation (Kang et al., 1998); they 
can reduce intracellular hydrogen peroxide induced by p53 (Wong et al., 2000), 
epidermal growth factor (Wong et a l, 2000) and tumor necrosis factor-a (Kang et 
al., 1998). Although compared to catalase or GPx, Prxs are thought to have 
moderate catalytic efficiencies, it is Prxs, but not GPx or catalase, which are 
reported to be negative regulators of PDGF signaling (Choi et al., 2005). Bacterial 
Prxs are also found to have peroxynitrite reductase activity (Bryk et al., 2000).
In Mycobacterium tuberculosis (Mtb), dihydrolipoamide dehydrogenase (Lpd) and 
dihydrolipoamide succinyltransferase (SucB) are components of the 2-oxoacid 
dehydrogenase complexes which play a very important role in metabolism. In these 
organisms the peroxiredoxin AhpC removes H2O2 in a system which lacks 
thioredoxin. Instead, AhpC is reduced by NADH via Lpd and SucB by a 
thioredoxin-like adaptor protein, AhpD (Bryk et a l, 2002). This interaction 
between antioxidant and metabolic pathways is unique and may provide important 
insights into the physiological roles of mitochondrial Pixs.
1.6 Prx evolution and the floodgate theory
The 2-Cys Prxs were originally identified as antioxidant enzymes but there is 
increasing evidence that they play important roles in H2 0 2 -mediated cell signaling 
as well.
The yeast Saccharomyces cerevisiae has at least five Prxs that have partially 
overlapping functions in detoxifying peroxides. In mammalian cells, Prxs typically 
constitute 0.1 to 0.8% of the total soluble protein of the cell (Chae et a l, 1999). 
Many organisms produce more than one Prx isoform. The abundance of Prxs may 
partly relate to their moderate catalytic proficiency; however, Prxs have received a 
great deal of attention recently owing to their role in regulating levels of hydrogen 
peroxide, an intracellular signaling molecule common to many cytokine-induced
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signal-transduction pathways (Hofmann et al., 2002).
Wood et al. (Wood et a l, 2003) found that bacterial 2-Cys Prxs are much less 
sensitive to oxidative inactivation than are eukaryotic 2-Cys Prxs. In bacteria, 
peroxiredoxins appear to be required only to protect against ROS. For example, in 
Escherichia coli, the abundant peroxiredoxin AhpC is the primary scavenger of 
H2O2 , generated during aerobic metabolism, and also detoxifies alkyl 
hydroperoxides. Recent in vivo studies show that human Prxl and PrxII are 
inactivated under conditions of peroxide signaling (Rabilloud et a l, 2002; Koshkin 
et a l, 2003) by irreversible over-oxidation of the peroxidatic cysteine to sulphinic 
acid (Cys-S02H) at a low steady-state level (<1 pM) of H2O2 . Wood et a l (2003) 
concluded that the sensitivity of 2-Cys Prxs to inactivation by over-oxidation is not 
a limitation of the 2-Cys Prx catalytic mechanism; rather it is a feature that has 
been selected for during the evolution of eukaryotes. This additional property of 
mammalian 2-Cys Pixs has led to the development of the floodgate model (Fig 
1.4). The activity of some Prxs also been shown to be regulated by phosphoiylation 
(Chang et al, 2002).
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Figure 1.4 A floodgate model for Prx-mediated regulating intracellular H2O2 levels
(A) The floodgate model o f peroxiredoxin (Prx) regulate H2O2 signaling. At low H2O2 
concentrations, active peroxiredoxin catalyzes the reduction o f H2O2 to H2O, preventing 
signaling. High H2O2 concentrations result in overoxidation o f  peroxiredoxin, thus 
preventing the reduction o f  H2O2 and allowing it to participate in signaling. (B) The 
peroxiredoxin catalytic cycle. (1) Oxidation o f the peroxidatic cysteine (Sp) to sulphenic 
acid by H2O2. (2 ) Attack o f the sulphenic acid by the thiol group o f the resolving 
cysteine ( S r )  results in the formation o f  a disulphide bond. ( 3 )  Reduction o f the 
disulphide bond by an external thiol-reducing agent such as thioredoxin. Other processes 
that involve the peroxiredoxin catalytic site are (4) inactivation o f peroxiredoxin by 
overoxidation o f the peroxidatic cysteine from sulphenic acid to sulphinic acid. Adapted 
from (Georgiou and Masip, 2003)
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1.7 Sulphiredoxin (Srx)
1.8 Molecular Chaperone Function
I
Srx is a new member of the antioxidant family in eukaryotes, first identified in 
yeast. Srx contains a C-terminal cysteine residue that is conserved in all family 
members. Studies with the yeast and human homologue show this residue is critical 
for its antioxidant function (Biteau et aL, 2003). Inactivated Prxs, caused by 
cysteine over-oxidation to cysteine sulphinic acid, can be reduced by Srx and ATP, 
although this over-oxidation was previously thought to be irreversible. A recent 
study on the molecular mechanism of the reduction of cysteine sulphinic acid of 
peroxiredoxin to cysteine by mammalian sulphiredoxin reveals that the presence of
the sulphinic form (but not the reduced foim) of Prxl induces phosphoiylation of 
the conserved cysteine of Srx and then the phosphate is immediately transferred to
Ithe sulphinic moiety of Prxl to generate a sulphinic acid phosphoiyl ester [Prx-Cys- 
SOOPO]^. This ester is reductively cleaved by a thiol molecule (RSH) such as 
GSH, thioredoxin and DTT to produce a disulphide-S-monoxide [Prx-Cys-S(=0)-
S-R]. The disulphide-S-monoxide is further reduced through the oxidation of three 
thiol equivalents to complete the catalytic cycle and regenerate Prx-Cys-SH (Jeong 
et a i, 2006). Interestingly, Srx is not found in prokaryotes. This could be because 
Srx is involved in the restoration of over-oxidized Prxs, whose counterparts in 
prokaryotes are not sensitive to oxidative inactivation as reported by Wood et a l 
(2003). This may suggest that Prx inactivation and recovery by Srx has been 
selected for during evolution (Biteau et a l, 2003).
Cytosolic Prxl and PrxII are found to be responsible for yeast survival during heat 
shock although the ability of cytosolic Prxl to protect the cells lacking PrxI/II from 
heat shock is not exclusively due to its peroxidase activity (Jang et a l, 2004). Jang 
et al also find that heat shock and oxidative stress induce a structural change in 
Prxl which results in a functional switch from a peroxidase to a molecular 
chaperone in vitro. They have developed a new model taking into account these 
additional obseiwations (Fig 1.5). At low ROS concentrations, Prxs form mainly 
low molecular weight species (dimers or oligomers) with peroxidase activity that 
remove low levels of ROS and regulate H2O2 signaling. However, when yeast are 
placed under extreme conditions like heat shock or oxidative stress, the
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peroxiredatic cysteine is overoxidised to cysteine sulfmic acid (-SO2H) and acts as 
a highly efficient “H202-sensor” with the help of the Trx system. The overoxidized
2-Cys Prxs then multimerize into a high molecular weight super-chaperone 
complex. That is postulated to aid cell survival under stress conditions. After 
oxidative stress, the Cys-sulphinic acid is reduced to Cys-SH by Srx in the 
presence of ATP and the high molecular weight complex gradually dissociates into 
low molecular weight species, thus restoring peroxidase activity. The molecular 
mechanisms by which Prxs function as chaperones are unclear at present as these 
recent data demonstrate solely that Prxs can enhance yeast survival under stress 
conditions.
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Figure 1.5 A M odel o f the Heat Shock or O xidative Stress-Dependent 
Structural and Functional Switching of cPrxI from a Peroxidase to a 
M olecular Chaperone
In normally growing cells, cPrxI exhibits both peroxidase and chaperone 
activity with a mixture o f different oligomeric states. However, during heat 
shock or oxidative stress, Prxs are overoxidised and shift to a high molecular 
weight state with the help o f the Trx system to act as super-chaperones. Srxl 
is essential for the dissociation o f complexes into low molecular weight 
protein species. Taken from (Jang et a l ,  2004).
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1.9 PrxIII
PrxIII (also called SP-22) is a small (22kDa) mitochondrial protein that was
originally isolated from bovine adrenal cortex as a substrate protein for a
mitochondrial ATP-dependent protease (Watabe et a l, 1994; Watabe et a l, 1995).
Analysis of its amino acid sequence revealed that PrxIII is a member of the Pi"x
family and belongs to the typical 2-Cys PrxIII subclass. Among the members of
this family, PrxIII is the only protein specifically located in mitochondria. PrxV, an
atypical 2-Cys Prx, is localized intracellulaiiy to mitochondria but also to cytosol
and peroxisomes (Seo et a l, 2000). Owing to the limited study of Pi*xIII at present,
its exact physiological flinction in vivo and the biochemical mechanisms involved
remain to be fully concluded. However PrxIII has been demonstrated to protect 
.several free-radical sensitive enzymes from oxidative damage in vitro (Watabe et 
a l,  1997). In vivo, current results indicate that PrxIII plays a crucial role in the 
antioxidant defence mechanism of mitochondria in the cardiovascular system 
(Araki et a l, 1999) and is also found to protect hippocampal neurons from 
excitotoxic injury (Hattori et a l, 2003).
"«i
Î
A recent RNAi study in HeLa cells suggests PrxIII depletion promotes increased 
intracellular levels of H2O2 and sensitizes cells to induction of apoptosis by 
staurosporine or TNF-a (Chang et a l, 2004). The authors conclude that PrxIII is a 
critical regulator of the abundance of mitochondrial H2O2 , which itself induces 
apoptosis with other mediators of apoptotic signaling.
The amino acid sequence of Pi-xlII has been determined, in both its precursor and 
mature forms (Hiroi et al, 1996). PrxIII has a 62 amino acid long mitochondrial 
targeting presequence. By comparison with other 2-Cys Prxs, PrxIII also contains 
the conserved peroxidatic cysteine (C47), the resolving cysteine (C l68) and a third 
cysteine residue C66.
The specific localization of Prx III in mitochondria (Araki et a l, 1999) together 
with the identification of its mitochondrial-specific electron suppliers, thioredoxin 
2 (Trx2) and thioredoxin reductase 2 (TRR2) (Spyrou et al., 1997; Lee et a l, 
1999), suggest that these three proteins might cooperate to provide a primaiy line 
of defence against H2O2 produced by the mitochondrial respiratory chain (Miranda-
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Vizuete et al., 2000; Pedrajas et a l, 2000). Moreover, it has been shown that PrxIII 
is 30-fold more abundant in the mitochondria of HeLa cells than is GPxl and is a 
critical regulator of the mitochondrial H2O2 concentration, in contrast to the widely 
held view that GPxl is the only important H2 0 2 ~metabolizing enzyme in 
mitochondria (Turrens, 1997; de Haan et a l, 1998; Kokoszka et a l, 2001).
Transmission electron microscopy has shown that bovine PrxIII exists as an 
oligomeric ring, with external and internal diameters of 150 and 70 Â, respectively 
(Gourlay et a l, 2003). The size of the ring is larger than other typical 2-Cys Prxs 
that exist as decamers.
1,10 Thioredoxin (Trx)
Thioredoxins are a family of proteins containing a conserved catalytic site (-Trp- 
Cys-Gly-Pro-Cys-Lys-) that undergoes reversible oxidation to the cysteine 
disulphide through the transfer of reducing equivalents from cysteine residues to a 
disulphide substrate (X-S2). The oxidized thioredoxin is then reconverted back to 
its reduced form by an NADPH-dependent thioredoxin reductase.
Human Trxl is a small, compact protein (104 amino acids) with a Mr value of 12 
kDa (Deiss and Kimchi, 1991). A slightly larger form was first identified in pig 
heart mitochondria (Bodenstein and Follmann, 1991). This second Trx, Trx2, was 
cloned from a rat heart library and contained a putative 60 amino acid long N- 
terminal mitochondrial targeting signal. Including the leader sequence, Trx2 is 
synthesised initially as a 166 amino acid, 18 kDa precursor protein containing the 
conserved Trx catalytic site but lacking the other Cys residues found in mammalian 
Trxl (Spyrou 1997).
The molecular basis for the reducing action of Trx is that substrate X-S2 binds to a 
conserved hydrophobic surface and in the hydrophobic environment of the 
complex, the thiolate of Cys31 acting as a nucleophile, combines with the protein 
substrate to form a covalently linked mixed disulphide (-Cys31 -S-S-protein). 
Finally, the now deprotonated Cys34 attacks the -Cys31 -S-S-protein disulphide 
bond, releasing the reduced protein substrate and forming a Cys31-Cys34 
disulphide bond in Trx, which is then reduced by thioredoxin reductase (Holmgren,
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1995).
Although Trxl forms homodimers in solution and in the ciystal structure (Wcichsel 
et a l, 1996), it is not yet clear if dimer formation occurs under physiological 
conditions. The ciystal structure of Trx2 shows that the folding of Trx2 is similar to 
that of human Trxl and dimerization still occurs in the crystal structure mainly 
mediated by hydrophobic contacts (Fig 1.6a) (Smeets et a l, 2005).
The physiological roles of Trxs in different organisms range from a common 
fundamental reaction to a series of different specialized functions. Their primary 
highly conserved role is as a high-capacity hydrogen donor system for reductive 
enzymes to highly specialized functions such as forming a complex with apoptosis 
signal-regulating kinase 1 preventing downstream signalling for apoptosis (Saitoh 
et a l, 1998). Trxs are also implicated in the onset and progression for a number of 
human diseases including cancer, viral infection, ischaemia-reperfusion injury, 
aging and cardiac conditions (Burke-Gaffney et a l, 2005), Studies on Trx2 are 
limited but Trx2 has been shown to interact with specific components of the 
mitochondrial respiratory chain, play a key role in the regulation of the 
mitochondrial membrane potential (Damdimopoulos et a l, 2002) and also in 
protection against peroxide-induced apoptosis (Chen et a l, 2002).
1.11 Thioredoxin reductase (TRR)
Thioredoxin reductase is the only enzyme that is known to be able to reduce the 
active site of thioredoxin with the use of electrons from NAD PH (Tamura and 
Stadtman, 1996). It belongs to a superfamily of flavoprotein disulphide 
oxidoreductases that includes glutathione reductase (GR), dihydrolipoamide 
dehydrogenase, mercuric reductase and alkylhydroperoxide reductase (Russel and 
Model, 1988). Mammalian TRR is distinct from those of prokaryotes and yeast. 
The mammalian enzyme exhibits a broader substrate specificity, having the ability 
to reduce chemically unrelated compounds and is larger in subunit size (58 kDa, 
compared with 35 kDa for the prokaryote and yeast enzymes), as it contains a 
much longer C-terminal region (Gasdaska et a l, 1995; Zhong et a l, 1998). In 
addition, mammalian TRR is a selenoprotein that contains a penultimate
20
I:
selenocysteine (SeCys) residue in the sequence -Gly-Cys-SeCys-Gly (Stadtman, 
1996; Tamura and Stadtman, 1996), which serves as a redox centre (Arscott et a l, 
1997).
.Two full-length human thioredoxin reductases have been cloned, a 54.4 kDa
thioredoxin reductase-1 , which is predominantly in the cytosol (Gasdaska et a l,
1995), and a 56.2 kDa thioredoxin reductase-2, which has a 33-amino-acid N-
terminal extension identified as a mitochondrial import sequence (Lee et al., 1999).
A third, incomplete thioredoxin reductase sequence has been reported (Pedrajas et
a l, 1999). The overall structure of the SeCys498Cys mutant of rat TRRl is similar
to that of glutathione reductase (GR), including conserved amino acid residues 
.binding the cofactors FAD and NADPH with the two subunits in a head-to-tail 
aiTangement (Fig 1.6b) (Sandalova et a l, 2001). The electrons are first transferred 
from NADPH to FAD and then the C-terminal sclenenylsulphide bond from the 
adjacent subunit is reduced by FAD. At this stage the Cys-SeCys acts as a second 
redox centre in which the electrons are transferred from this redox-active seleno- 
sulphide to the substrate Trx (Fig 1.7) (Zhong et a l, 1998; Zhong et a l, 2000). 
Mutagenesis of TRRl in which SeCys is replaced by Cys shows that the TRRl 
mutant lacks hydroperoxidase activity. Therefore selenium is required for catalytic 
activity. TRRl is also involved in many aspects of cellular redox regulation (Sun 
and Gladyshev, 2002). It is capable of inducing apoptosis if the enzyme does not 
contain selenocysteine or if this residue is blocked by chemotherapeutic agents 
(Anestal and Arner, 2003). A TRR2 mouse knockout study shows an essential role 
for TRR2 in hematopoiesis, heart development, and heart function (Conrad et a l, 
2004). In this study also, cardiac tissue-restricted ablation of TRR2 results in fatal 
dilated cardiomyopathy, a condition reminiscent of that observed in Keshan disease 
and Friedreich's ataxia.
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Figure 1.6 Crystal Structure of (a) human Trx2 and (b) rat 
TR R l SeCys498Cys
Taken from (Biterova et a i ,  2005) and (Zhong et a l ,  2000).
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Figure 1.7 Postulated reaction mechanism for mammalian TRR
The upper part of each figure shows a FAD centre and the lower part 
shows the Cys-SeCys redox centre from adjacent subunit. Taken from 
(Zhong et al., 2000).
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i1.12 Mammalian SeCys enzymes
Although most derivatives are toxic, selenium is recognized as an essential trace
element for health. It is incoiporated into proteins to make selenoproteins, most of
which are important anti oxidant enzymes. After glutathione peroxidase (Rotruck et
al., 1973), the first specific mammalian selenoprotein discovered, it has been
estimated that there are 25 human selenoproteins through genomic analysis
(Kryukov et a l, 2003). Until now, only two types of seleno amino acids have been
found in proteins, selenomethionine (SeMet) and selenocysteine (SeCys). However,
in normal cellular metabolism methionine and selenomethionine are essentially
treated equally (Birringer et a l, 2002). Due to the unselective nature of 
.selenomethionine incorporation, the physiological relevance of SeMet is still 
unknown. On the other hand, UGA, noiinally interpreted as a stop codon, is also 
the codon for the 2V  ^ amino acid, selenocysteine, with additional signals. Unlike 
SeMet, SeCys is incorporated specifically into proteins. In mammalian cells, it is 
incorporated into SeCys proteins by a translational recoding event at specific UGA 
codons. These are found upstream of stable stem-loop structures known as SeCys 
insertion sequences (SECIS) that reside in the 3'-untranslated region (UTR). A 
minimum distance of 58-111 nucleotides up to a maximum of 5.4 kb in an extreme 
case (Buettner et a l, 1998), has been identified between the SECIS and its cognate 
upstream SeCys-encoding UGA (Low and Berry, 1996; Grundner-Culemann et a l, 
1999). While the UGA codon and the SECIS element are the only known cA-acting 
elements required for SeCys incorporation, at least three trans-^oXmg factors are 
also required: 1) the SeCys-specific elongation factor (EFSeCys), 2) a SECIS- 
binding protein (SBP2), and 3) the tRNASeCys. Our understanding of the 
mechanism of SeCys incorporation into polypeptides is still not totally clear.
Both selenium and sulphur are members of the Group VI elements and hence have 
similar properties. However, the redox potential of selenium compounds is lower 
compared to their respective sulphur-containing equivalents. Furthermore, 
selenium compounds are generally more reactive (Huber and Criddle, 1967). 
Studies have shown that selenoenzymes use SeCys because it expands the 
metabolic capacity of enzymes in terms of activity toward a wider variety of 
substrates and over a broader range of pH (Gromer et a l, 2003).
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Selenoenzymes have long been known to play important roles in protection from 
oxidative stress and the damaging effects of reactive oxygen species. The 
glutathione peroxidases, the best characterized family of selenoenzymes, were 
originally thought to be solely responsible for anti-oxidative defence. Many studies 
show that overexpression of GPx-1 can protect cells against reactive oxidative 
species, for example, damage caused by hydrogen peroxide and lipid 
hydroperoxides and redox cycling compounds such as paraquat (Taylor et a l, 
1993). However, overexpression of GPx-1 can also inhibit hydrogen peroxide- 
induced apotosis in cell lines (Laskowski et a l, 1993). By using alternative splice 
sites, GPx4 can generate mitochondrial and cytoplasmic isoforms. GPx4 also 
exhibits the broadest substrate specificity of all glutathione peroxidases and can 
even reduce phospholipid hydroperoxides. It is also capable of reducing hydrogen 
peroxide still present in membranes and may thus play a role as a universal 
antioxidant in the protection of biomembranes (Ursini el al., 1985). GPx4 is also
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involved in redox signaling and regulatory processes, such as inhibiting 
lipoxygenases and apoptosis (Brigelius-Flohe, 1999).
Defects in selenoproteins are also implicated in a few diseases. The most prominent 
examples in humans are Keshan disease, a dilatative cardiomyopathy primarily 
affecting children (Ge et a l, 1983), and Kashin-Beck disease, a disabling 
chondronecrosis (Peng et a l, 2000).
1.13 Structural Biology
Currently, electron microscopy and small angle scattering are used to obtain low- 
resolution structural information. Although the resolution is relatively low (10- 
25Â), these techniques give valuable information about large protein complexes 
and, in combination with high-resolution data, provide us a with a comprehensive 
picture of how proteins interact with each other in multi-component complexes.
To obtain detailed stmctural information on a protein of interest, high-resolution 
data are needed. X-ray crystallography and NMR spectroscopy are the two 
techniques of choice for solving high-resolution structures of macromolecules. X-
1.
ray crystallography is the traditional approach that gives the best resolution. 
However, a major rate limiting step is often the production of good quality crystals. 
NMR spectroscopy does not give as high resolution as X-ray crystallography; 
moreover, the protein must be relatively small (normally less than 50 kDa). NMR 
has its own advantages as structures are determined in solution, which may be 
closer to noiTnal physiological conditions. In addition, mobile loops of the protein 
can be “seen” by NMR whereas they are normally not sufficiently ordered to be 
visualised in crystallography.
The Protein Data Bank (PDB) is the single worldwide repository for the processing 
and distribution of 3-D structural data relating to large molecules, namely proteins 
and nucleic acids. Every year the number of deposited structures in the PDB is 
increasing dramatically, especially in the past ten years (Appendix I), The vast 
majority of structures of biological macromolecules have been determined by 
protein crystallography. There are several factors contributing to the success of this 
approach. Firstly, recombinant DNA methods have made it possible to clone, 
express and purify large quantities of the majority of biological macromolecules. 
Secondly, rapid and improved automated methods are introduced each year. In 
addition, synchrotrons provide intense sources of X-rays, while new detectors 
allow rapid data collection. Thirdly, new and powerful software for crystal 
structure determination as well as cheaper and more powerful computers have also 
reduced the time for data processing and analysis. With these advantages, not only 
the number of structures, but also the complexity of structures in the PDB is 
increasing rapidly (Appendix II). Therefore, the focus of structural biology is 
gradually moving towards the analysis of macromolecular interactions in the cell, 
including attempts to capture the dynamic nature and high precision of localized 
interactions, as well as the involvement of multiple ligands.
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1.14 X-ray Crystallography
A well-ordered crystal that will diffract X-rays strongly is the first requirement for 
solving the three-dimensional structure of a protein by X-ray ciystallography. After 
that an X-ray beam will interact with the crystal, which is a regular, repeating array 
of many identical molecules, so that the X-rays are diffracted from it in a 
diffraction pattern, from which the structure of an individual molecule can be 
retrieved. The repeating unit forming the crystal is called the unit cell. Each unit 
cell may contain one or more molecules.
There are several techniques for setting up crystallization experiments including 
sitting drop vapour diffusion, hanging drop vapour diffusion, sandwich drop, batch, 
microbatch, under oil, microdialysis, and free interface diffusion. Sitting and 
hanging drop methodologies are most popular because they are easy to perform, 
require a small amount of sample, and allow a large amount of flexibility during 
screening and optimization.
Using the sitting drop technique (Fig 1.10), a small (0.5 to 20pl) droplet of the 
sample is mixed with crystallization reagent on a platform in vapour equilibrium 
with the reagent such that the initial reagent concentration in the droplet is less than 
that in the reservoir. Over time the reservoir will remove water from the droplet in 
the vapour phase until equilibrium is reached between the drop and the reservoir. 
During this equilibration process the protein is concentrated, increasing the relative 
supersaturation of the protein in the drop. The advantages of the sitting drop 
technique are that it is convenient and simple to use. The disadvantages are that 
crystals can sometimes stick to the sitting drop surface which makes “looping out” 
of crystals difficult. The sitting drop technique is a good routine choice for 
screening and optimization.
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Reservoir
Figure 1.10 Sitting drop crystallization technique
When an X-ray beam hits the crystal, most o f the X-rays travel straight through it. 
Some, however, interact with the electrons on each atom and cause them to 
oscillate. The oscillating electrons serve as a new source o f  X-rays which are 
emitted in almost all directions as scattering. X-ray scattering from a single 
molecule would be unimaginably weak and could never be detected above the 
noise level, which would include scattering from air and water. A crystal arranges 
huge numbers o f molecules in the same orientation, so that scattered waves can add 
up in phase and raise the signal to a measurable level. In a sense, a crystal acts as 
an amplifier. Diffraction by a crystal can be regarded as the reflection o f the 
primary beam by sets o f parallel planes. The relationship between the reflection 
angle, 0, the distance between the planes, d, and the wavelength, X, is given by 
Bragg’s law (Fig 1.11).
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atomic planes
2 d sin0  = nX
Figure 1.11 Bragg’s Law
A set o f parallel planes with interplanar spacing, d, produces a diffracted beam 
when X-rays o f wavelength X impinge on the planes at an angle 0 and are 
reflected at the same angle. If the difference in path length (that is 2a, also 2d 
sin0) for Rayl and Ray2 from successive planes is equal to an integral number 
of wavelengths o f the X-rays (nX), then they will produce a strong diffracted 
beam.
Each atom in a crystal scatters X-rays in all directions, and only those that 
positively interfere with one another, according to Bragg’s law, give rise to 
diffracted beams that can be recorded as a distinct diffraction spot above 
background. Each diffraction spot is the result o f interference o f all X-rays with the 
same diffraction angle emerging from all atoms. To extract information about 
individual atoms from such a system Fourier transform analysis is employed. Each 
diffracted beam, which is recorded as a spot on the detector, is defined by two 
properties: the amplitude, which can be measured from intensity o f the spot; and 
the phase, which is “lost” in X-ray experiments. Both properties for all o f  the 
diffracted beams have to be known to determine the position o f the atoms. This is 
the so-called phase problem in X-ray crystallography. There are quite a few 
methods available now for solving the phase problem.
When identical or similar structures exist in different crystallographic 
environments, similarities between their diffraction patterns, which are directly 
related to their Fourier transforms, would be expected. The technique o f Molecular 
Replacement (MR) uses this similarity to determine phases. Molecular replacement
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is usually a two-step process. Firstly, the orientation of the search model is found 
from the rotation function and then, the position of the search model is found using 
the translation function. In recent years with access to more and more powerful 
computers, some programs like PHASER employing maximum likelihood methods 
have made it possible to obtain large scale improvement in relatively poor datasets.
Phase information can also be obtained by multiwavelength anomalous diffraction 
(MAD) experiments. For certain X-ray wavelengths, the interaction between the X- 
rays and electrons of an atom causes the electrons to absorb the energy of the X- 
ray. This causes a change in the X-ray scattering of the atom, called anomalous 
scattering. The intensity differences obtained in the diffraction pattern by 
illuminating such a crystal with X-rays of different wavelengths can be used to 
obtain the phases of the diffracted beams. The MAD method requires access to 
synchrotron radiation since different wavelengths are used.
The amplitudes and the phases of the diffraction data from the protein crystals are 
used to calculate an electron-density map of the repeating unit of the crystal. This
map then has to be interpreted as a polypeptide chain with a particular amino acid 
sequence. The quality of the map depends on the resolution of the diffraction data, 
which in turn depends on the degree of order in the original crystals. The initial 
model will contain errors, which can be subsequently removed by crystallographic 
refinement of the model. In this process the model is changed to minimize the 
difference between the experimentally observed diffraction amplitudes and those 
calculated for a hypothetical crystal containing the model instead of the real
.molecule. This difference is expressed as an R factor, residual disagreement, which 
is 0 for exact agreement and around 0.6 for total disagreement. In general R factors 
should be between 0.15 and 0 . 2 0  for a well-determined protein structure but also 
depends on resolution, number of reflections, the refinement and other parameters.
In refined stractures at high resolution there should be no major errors in the 
positions of all atoms.
1.15 Research Aims
The major goals of this research programme were (a) to obtain a detailed picture of 
the mitochondrial antioxidant defence pathway involving PrxIII; (b) to study the 
properties of the reconstituted pathway in detail and analyse the effect of various 
point mutations in its key enzyme and (c) to conduct detailed structure (X-ray 
crystallographic) studies on PrxIII.
Initial research was directed towards the cloning and expression of the human 
mitochondrial isofonns of thioredoxin, Trx2 and thioredoxin reductase, TRR2 in 
high yields to facilitate their purification in sufficient quantities to permit the 
reconstruction of the complete, 3-component antioxidant pathway in vitro. This 
was successfully achieved as described in chapter 3 although overexpression of 
active, SeCys-containing TRR2 required the insertion of a selenocysteine insert 
sequence (SECIS) at the 3’-end of the open reading frame. The presence of the 
SECIS is required for promote incorporation of a SeCys residue at the appropriate 
UGA codon which normally functions in termination of translation, A number of 
other genetic tricks were also employed to optimise the expression of active, 
soluble TRR2.
In chapter 4, the successful reconstitution of the PrxIII pathway is described and 
the pathway is characterised with respect to its substrate specificity, H2O2 
concentration dependence and susceptibility to inactivation by overoxidation. The 
oxidation of PrxIII and the appearance of abnormal oxidation states was also 
detected by SDS-PAGE. Finally, the protein concentration, redox state dependence 
and the influence of the N-terminal Flis-tag on the stability of the toroidal form of 
PrxIII was also investigated.
Comprehensive crystallographic trials were conducted on wild-type PrxIII and 
various active-site mutants. However, only the C168S mutant produced well- 
ordered ciystals that were employed subsequently to solve a 3-D structure of this 
enzyme to 3.3 Â as described in chapter 5. A number of difficulties were 
encountered during the data processing so several different approaches and a 
variety of programs were employed before a final solution could be obtained.
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In Chapter 6 , the remarkable subunit organisation of PrxIII was analysed in detail 
and compared to other Prxs stmctures. A model is proposed which accounts for the 
tendency of PrxIII to assemble into a 2-ring catenane.
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Materials and Methods
2.1 Molecular biology reagents
2.1.1 Enzymes
Restriction endonucleases and calf intestinal alkaline phosphatase (CIAP) were 
purchased from Roche, T4 DNA ligase and Pfu DNA polymerase were purchased 
from Promega.
2.1.2 Kits
Wizard® Plus Mini Preps purification system was purchased from Promega. The 
QlAchange Gel extraction kit was purchased from QIAGEN.
2.1.3 Molecular weight marker
The Ikb DNA Step Ladder, supplied with Blue/Orange Loading Dye (6 X) was 
purchased from Promega.
2.1.4 Synthetic oligonucleotides
Primers for gene amplification by Polymerase Chain Reaction (PCR) were 
designed in house and synthesized by Sigma (25 mmole scale).
2.1.5 Bacterial strains
Escherichia coli DH5a (Stratagene, Amsterdam, The Netherlands) and Escherichia 
coli BL21 (DE3) pLysS and BL21 (DE3) CodonPlus (Novagen, Nottingham, UK) 
bacterial strains were used for propagation of plasmid vectors and the expression of 
recombinant proteins employing the pET vector system, respectively. E. coli M15 
cells were used for expression of recombinant protein employing the pQE vector 
system.
2.1.6 Growth of bacterial cells
Luria Broth (LB) (1% (w/v) bacto-tryptone, 1% (w/v) NaCl, 0.5% (w/v) yeast 
extract, pH 7.2) or LB/agar plates (LB containing 1.5% (w/v) agar) were the
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2.1,8 Plasmid vectors
pET-14b vector was purchased from Novagen and pQE-31 vector was purchased 
from QIAGEN.
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growth media of choice for most bacterial strains. When appropriate, media were 
supplemented with ampicillin (50pg/ml), kanamycin (30p,g/ml) or chloramphenicol 
(34p.g/ml).
Modified-rich LB (Rich LB) (0.5% (w/v) NaCl), 1.2%(w/v) Bactotryptone, 
2.4%(w/v) yeast extract, 4.0% (v/v) glycerol, 0.5%(w/v) K2HPO4 and
0.0142%(w/v) N8 2 8 0 4 ) with appropriate antibiotics, as indicated above, were the 
growth media of choice for production of recombinant mitochondrial thioredoxin 
reductase.
2.1.7 M9 medium
5x M9 stock: 3%(w/v) Na2HP0 4 , 1.5%(w/v) KH2PO4 , 0.5%(w/v) NH4CI, 0.25%
(w/v) NaCl was first autoclaved to prepare the M9 medium. M9 medium (11) was 
made from: 200ml 5x M9 stock, 700ml water (autoclaved), 1ml IM MgS0 4  stock,
'100ml 4% (w/v) glucose stock (sterile filtered), lOOp-1 0.5% (w/v) thiamine (sterile 
filtered), 1ml FeS0 4 , 4.2g/l (sterile filtered) and the required antibiotic.
2.2 Molecular Biology Methods
2.2.1 Polymerase Chain Reaction (PCR)
1. 2. 3. 4, 6.
60 s at 95“C-^60 s at 95°C^60 s at 55"C-^2 min at 72°C-> Hold at 4"C
i  i
5. 30 cycles
The quality and quantity of PCR product obtained was analyzed by agarose gel 
electrophoresis.
Clones of human mitochondrial thioredoxin (Trx2) (IMAGE ID 5554051) and 
human mitochondrial thioredoxin reductase (TRR2) (IMAGE ID 5588243) 
obtained from Geneservice Ltd (lOOng) were used as the PCR template. The PCR 
reaction contained 5pi reaction buffer (lOx), Ipl dNTP mix (0.25mM each of 
dATP, dCTP, dGTP, and dTTP), Ipl (250ng) forward and reverse specific primers, 
and IplP/w  DNA polymerase (3U/pl) prepared in a total volume of 50pl with 
sterile dHiO. Amplification was carried out in a PTC-100™ programmable 
thermocycler (MJ Research Inc.). The typical reaction cycle comprising six steps 
is shown below:
2.2.2 Restriction Endonuclease Digestion of Insert and Vector DNA
Following PCR amplification, BamHl restriction endonuclease was used to 
generate sticky ends for ligation. Both insert and vector DNA (approx. 5pg) were 
digested in a reaction containing 3 pi of the appropriate buffer as provided by the 
manufacture (lOx), and 3pi BamHl (lOU/pl) made up to a total volume of 30pl 
with sterile dH2 0 . Digestion was carried out at 37°C for 3h.
 .
To prevent re-joining of the vector DNA during ligation, the 5' protmding termini 
were dephosphorylated immediately following restriction digestion. This was 
carried out by incubating the linear vector with 1 unit of calf intestinal alkaline 
phosphatase for 30 min at 37°C. The treated vector was then purified using the
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2.2.5 Production of Competent Cells
I
I
QIAquick® Gel Extraction Kit, purifying directly from the reaction mix. After each
' ' 'purification step, 5 pi of the insert DNA was analyzed on a 1.0% (w/v) agarose gel.
2,2.3 DNA Gel Electrophoresis
-DNA fragments were separated by agarose gel electrophoresis, prepared by 
dissolving the required amount of agarose, typically 0.7-2.5% (w/v) in (Ix) TAE 
buffer, pH 7.6. TAE buffer was prepared as a (lOx) stock in 1 litre (11.4ml glacial 
acetic acid, 20ml 0.5M EDTA and 48.8g Tris-HCl, pH 8.0). The gel was placed in
■an electrophoresis tank and submersed in TAE buffer (Ix). In general, 3 pi loading 
buffer (50% (v/v) glycerol, 0.01% (w/v) SDS, 0.01% (w/v) bromophenol blue) was
added to 5pi of DNA prior to electrophoresis which was carried out at 100 volts■(V) and 250 mA. DNA fragments were visualized by ethidium bromide (EtBr) 
staining in distilled water (0.5-1 pg/ml in dH^O) for 30 min with shaking at room
’■temperature. The gel was rinsed in dHzO to remove background stain, and then 
visualized under 320nm UV light. Photographs were taken with a Polaroid DS34 
direct screen-imaging camera, and recorded onto K65HM-CE glossy thermal film.
Where necessaiy, linear DNA fragments were excised from the gel using a scalpel, 
and subsequently purified using a Qiagen DNA gel extraction kit.
2.2.4 Ligation
Following BamHl treatment, the DNA encoding PrxIII, and pET-14b were joined
via the actions of T4 DNA ligase. Three ratios of plasmid to insert were prepared
(1:1, 1:3 and 1:7), in a reaction mix containing 2pl reaction buffer (lOx), 1.5pl T4 
.DNA ligase (3U/pl) diluted to 20pl with sterile dH2 0 . These were incubated at 
room temperature overnight before being transformed into competent E. coli DH5a 
cells following the standard protocol above. The resulting colonies were then 
screened to check for the presence of the insert of interest,
I
Competent cells were made using the rubidium chloride method. The appropriate 
bacterial E. coli strain was streaked overnight on a LB plate without antibiotics. A 
single colony was used to inoculate a 5ml overnight culture. This was subcultured 
into 100ml LB and grown at 37°C with shaking until the culture reached an optical
"i
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density of 0.5 at 600nm. The culture was then chilled for 5 min before 
centrifugation at 8,000g for 10 min at 4°C. The pellet was resuspended in 40ml 
buffer 1 (lOOniM rubidium chloride, lOmM calcium chloride, 50mM manganese 
chloride, 15% (v/v) glycerol in 30mM potassium acetate, pH 5.8). Cells were 
centrifuged as before and the pellet resuspended in 4ml buffer 2 (75mM calcium
:chloride, lOmM rubidium chloride, 15% (v/v) glycerol in lOmM MOPS buffer, pH 
6.5). The cells, now competent, were divided into aliquots and stored at -80°C.
-
2.2,6 Transformation of competent bacteria
To 50pl of competent bacteria, 1-1 Ong of DNA was added. The mixture was chilled 
for 15 min before heat shocking at 42*’C for 90s and returning to ice. After 2 min 
LB medium (450pl) was added and this was incubated at 37°C with shaking for 45 
min. This mix was plated on an LB plate containing the appropriate antibiotic and 
incubated overnight at 37°C.
Ï
2.2.7 Plasmid Propagation and Purification
Vector and recombinant plasmid DNA amplified in E. coli DH5a cells was purified 
from 5ml overnight cultures using a Wizard® Plus Mini Preps DNA purification 
kit. Purified DNA (5pi) was analyzed by agarose gel electrophoresis.
2.2.8 Expression of Recombinant Protein in Bacteria
A single colony was picked from a LB-agar antibiotic plate and grown at 37°C with 
shaking in 5ml growth media plus antibiotic for 16h. An aliquot was subcultured 
into 50ml of growth media plus antibiotic. Cultures were incubated at 37°C with 
shaking until an Aeoo of 0.5 was reached. Induction of heterologous protein 
expression was initiated by addition of ImM IPTG. Induction temperatures varied 
aceording to the protein of interest. Bacterial growth was monitored; samples 
( 1 ml) were removed at the point of induction and at regular intervals thereafter, and 
their absorbance recorded at 600nm. Cells were harvested by centrifugation in a 
bench top microfrige for 2 min; the pellet was resuspended in Laemmli sample 
buffer (10% (w/v) sucrose, 2% (w/v) SDS, 62.5mM Tris-HCl, pH 6 . 8  and a small 
amount of Pyronin Y dye), adding lOpl per 0.1-absorbance unit of original culture.
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2.2.9 Expression of SeMet Protein in Bacteria
1
Successful overexpression was determined following reducing SDS- 
polyacrylamide gel electrophoresis (SDS-PAGE) analysis.
A single colony was picked from an LB-agar antibiotic plate and grown at 37°C 
.with shaking in 5ml growth media plus antibiotic for 16h. The M9 medium was 
pre-warmed to 37°C. LB overnight cultures (1ml) were centrifuged at 13,000 rpm
for 1 min at room temperature and the cell pellet was gently resuspended in 1 ml of 
.M9 medium. The resuspended cell suspension was returned to a 250 ml culture. 
Growth was continued until Aôoo reached 0.3 which normally took 4-8h. Solid 
amino-acid supplements were added to the cultures to the final concentrations 
given; L-lysine lOOmg/1, L-phenylalanine lOOmg/1, L-threonine lOOmg/1, L- 
isoleucine 50mg/l, L-leucine 50mg/l, L-valine 50mg/l and L-selenomethionine 
50mg/l. After culturing for 15 min to permit inhibition of methionine synthesis, 
heterologeons protein expression was induced as normal (1 mM IPTG) at 22°C. 
Growth was continued for a further 16h before cells were harvested as described 
above.
2.2.10 Bacterial Ceil Lysis
Bacterial cells from small (50ml) cultures were harvested by centrifugation and 
resuspended in 5ml of the appropriate buffer. For large (500ml) cultures, bacterial 
cells were harvested and the pellet resuspended in 20ml of buffer. The bacterial 
extract was passed four times through a French Pressure Cell (AMINCO) at a 
pressure of 750Psi/950Psi for small/large cultures, to lyse the cells. Insoluble and 
soluble fractions were separated from the cell extract by centrifugation at 
10,000rpm for 15 min in a JA-17 rotor in a Beckman J2-MC centrifuge.
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2.3 Materials for Protein Purification and Analysis
2.3.1 Chemicals
The following chemicals were purchased from Sigma Chemical Co, Poole, Dorset, 
UK: benzamidine, DL-6 ,8 -thioctic acid amide (DL-lipoamide, oxidized form), 5,5'- 
dithionitrobenzoic acid (DTNB), hydrogen peroxide (H2O2), N-(2- 
hydroxyethyl)piperazine-N'-(4-butanesulphonic acid) (HEPES), imidazole, 
leupeptin, (3-nicotinamide adenine dinucleotide, reduced form (p-NADH), (3- 
nicotinamide adenine dinucleotide 2 '-phosphate, reduced form ((3-NADPH), 
potassium phosphate (KH2PO4), tiichloroacetic acid (TCA). DTT was bought from 
Melford Laboratories Ltd., Suffolk, UK. All chemicals were at least of analytical 
grade. Distilled water was of Millipore-Q quality,
2.3.2 Molecular Weight Markers and Equipment
The Low Molecular Weight Marker Kit was purchased from Amersham Pharmacia 
Biotech UK Ltd, for subunit molecular weight determination of proteins run on 
denaturing SDS-PAGE. The calibration mix was supplied as a lyophilized sample 
containing six highly purified proteins with a Mr range of 14,400-94,000. The 
ealibration mix (250pg) was resuspended in 250pl Laemmli sample buffer (section 
2.2.8) to give a IX concentration, and lOpl was routinely loaded on a gel. The 
subunit Mr value of the protein of interest was determined by comparing its 
electrophoretic mobility with that of the molecular weight standards.
A pre-packed HiPrep (16mm x 600mm), Sephacryl S-300 High Resolution column 
was purchased from Pharmacia with a bed volume of 120ml and fractionation 
range of 1 X 10"^ - 2 X 10  ^ M,-. The column was run using a BioCAD® 700E 
Perfusion Chromatography® Workstation.
The BioCAD® SPRINT™ and BioCAD 700 Series Perfusion Chromatography® 
Workstations and SelfPack POROS 20 Metal Chelate Affinity Packing equipment 
were purchased from PerSeptive Biosystems, Framingham, MA, U.S.A. Chelating 
Sepharose® Fast Flow gel matrix was purchased from Amersham Pharmacia 
Biotech.
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2.3.3 Spectrophotometrîc Equipment
Ail spectrophotometrîc measurements for enzyme assays, protein concentration 
determination, and Ellman’s assay, were recorded using an Ultrospec 4300 Pro 
UV/Visible spectrophotometer (Biochrom). UV quartz cuvettes (1ml, Jencons) 
with a 1 0 mm pathlength were used routinely.
:S
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2.4 Protein Methods
2.4.1 Preparation of the Metal chelate Affinity Columns
Metal chelate chromatography used to purify His-tagged proteins was carried out 
using a BioCAD® SPRINT™ or BioCAD 700 Workstation. A column (10mm x 
100mm) with a bed volume of 8.5ml was packed with Self Pack POROS 20 Metal 
Chelate Affinity Packing according to the manufacturer’s instructions. Zinc ions 
(Zif^) were loaded onto the matrix by passage of 24 column volumes (CV) of 
O.IM ZnCh at a low pH of 4.5-5.0 to minimize precipitation of metal hydroxide 
complexes. The column was then washed with 5 CV of dHzO to remove excess 
zinc ions followed by 5 CV of 0.5M NaCl to remove non-specifically bound metal 
ions. To improve selectivity and recovery of the His-tagged protein, the column 
was saturated with elution buffer (0.5M imidazole, l.OM NaCl, 20mM HEPES 
buffer, pH 6.0). The metal chelate column was primed with 5 CV of starting buffer 
(0.5mM imidazole, l.OM NaCl, 20mM HEPES buffer, pH 8.0) prior to protein 
loading.
2.4.2 Purification of His-tagged protein
Bacterial cultures (500ml) were routinely employed in purification of high yields of 
protein per single purification. Bacterial cell lysis was performed as described in 
section 2.2.10. The clarified supernatant of the extract was maintained on ice for 
further purification. Four 5ml injection steps were incorporated into the BioCAD 
elution protocol to load the 20ml sample onto the metal chelate affinity column. An 
increasing imidazole gradient, from 0.5mM - 0.5M over 6  CV was carried out, 
eluting the His-tagged protein in 2ml fractions. Column regeneration was achieved 
by stripping with l.OM NaCl containing 50mM EDTA followed by a water wash. 
The column was stored in dHzO or 20% (v/v) ethanol for longer time periods. 
Fractions were stored at 4°C.
I
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2.4.3 Preparation of BioCAD Protein Fractions for SDS-PAGE
enable clear band visualization.
Following elution of the His-tagged recombinant protein, aliquots (20pi) of peak
fractions were mixed with 20pl Laemmli sample buffer supplemented with DTT 
(150mM) for subsequent SDS-PAGE analysis.
2,4.4 SDS-PAGE
Electrophoresis of protein samples was canied out in SDS, according to the method
of Laemmli (1970). Each gel comprised a 3% stacking gel and a 10-15% resolving 
.gel depending on the molecular weight of the protein of interest. Polymerization of 
the gel was achieved on addition of 0.03% (v/v) TEMED, and 0.05% (w/v) 
ammonium persulphate (APS) to a 30:0.8 ratio of aerylamide:bisaerylamide. 
Typically a lOpl sample was loaded per well. Electrophoresis was earned out at a 
constant voltage (400V) and 50mA/gel in IX SDS running buffer prepared from a 
lOX stock (144g glycine, lOg SDS and 29.8g Tris-HCl, pH 8 . 8  prepared to 11 with 
distilled water). Protein bands were stained with Coomassie Brilliant Blue G250 in 
50% (v/v) methanol and 10% (v/v) glacial acetic acid with shaking for 30 min at 
room temperature. The gel was immersed in an appropriate volume of destain 
( 1 0 % (v/v) methanol and 1 0 % (v/v) glacial acetic acid) to remove excess stain and
For superior resolution when necessary, samples were run on pre-cast 4-12% 
NUPAGE®Novex Bis-Tris gels (Invitrogen) held within a XCell SureLock" Mini- 
Cell. The preparation of protein samples for electrophoresis was the same as for 
standard SDS-PAGE. Electrophoresis was carried out in IX NUPAGE® MES SDS 
Running buffer at constant voltage (200V) and 11 OmA/gel. The staining procedure 
was as for conventional SDS polyacrylamide gels.
2.4.5 Protein Dialysis and Concentration
Peak fractions following metal chelate chromatography were pooled and dialyzed 
routinely against 101 of dialysate (5 x 21 changes) at room temperature or 4°C. 
Dialysis tubing had a molecular weight cut-off of 10,000 Mr. The dialysate was 
typically 150mM NaCl, 50mM HEPES, pH 7.2 for the majority of experiments.
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2.4.6 Determination of Protein Concentration
Gel exclusion chromatography was performed at room temperature using a pre­
packed HiPrep 16/60 Sephacryl S-300 High Resolution column connected to a 
BIOCAD® 700E Perfusion Chromatography® Workstation. The flow rate was 
Iml/min and the volume of protein loaded was 1ml (recommended < 2% of bed 
volume). Fractions (2ml/tube) were collected. All buffers were filtered through a 
0.2pm vacuum filter (Millipore). The column was equilibrated with 2 CV of the 
appropriate buffer, washed with 2 CV of dHiO between runs and stored in 20% 
(v/v) ethanol for longer periods.
Protein concentration was determined according to the absorbance of the protein at 
.280nm. To determine the Aaso, it was necessary to derive an extinction coefficient 
for the protein under investigation. The protein was analyzed in the far UV
'spectrum over 240~400nm, using buffer only as the reference. The extinction 
coefficient was calculated using the following equation:
No. of Tiwptophan Residues x 5690 + No. of Tvrosine Residues x 1280 
Monomeric molecular weight of Protein
The Algo divided by the extinction coefficient enabled protein concentration 
determination. The extinction coefficient for PrxIII (1 mg/ml) was 0.735, for TRR2 
was 1.053 and for Trx2 was 0.485. In all cases the A28q:A26o ratio of the protein was 
checked to ensure minimal DNA or RNA contamination.
i:
2.4.7 Anion exchange
Anion exchange chromatography was performed on a BioCAD SPRINT™ or 
BioCAD 700 Workstation at room temperature with a POROS® HQ column. The 
sample buffer was exchanged with 50mM Tris-HCl, pH 8.5. A gradient of IM
NaCl in 50mM Tris-HCl, pH 8.5 was used to elute the protein from the HQ column 
over 30CV.
2.4.8 Gel Filtration
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2.4.9 Ellman Assay for Thiols
Protein samples of known concentration were prepared in 150mM NaCl, 50mM 
HEPES, pH 7.0. The amount of nitrothiobenzoate (NTB) released upon reaction of 
a thiol with DTNB was measured by monitoring the absorbance at 412nm. The 
absorbance was set to zero with a 1ml protein sample. To the protein sample, 25pi 
lOmM DTNB prepared in O.IM HEPES, pH 7.0 was added and inverted to mix. 
The absorbance was recorded over 40 min at room temperature. The absorbance 
difference between the protein sample and the buffer only control was measured. 
The absorbance of the TNB anion ( £ 4 1 2  = 14,150M'^cm‘*) produced was used to 
calculate the molar concentration of the thiols present:
pM protein x £4 1 2 = Expected A4 , 2  per thiol.
2.4.10 Cleavage of His-tag from protein
The serine protease thrombin, supplied as a lyophilized powder, was used to cleave 
recombinant fusion proteins containing a His-tag. Cleavage was achieved by 
overnight incubation at room temperature with the protein (lU  cleaves a 90% of 
lOOpg protein). Protein with intact His-tag was removed by metal affinity 
chromatography using a PD-10 column prepared with 2ml of Chelating 
Sepharose®  Fast Flow (Amersham Pharmacia Biotech Ltd.) employing 
immobilized zinc ions according to the manufacturer’s instructions. Successfully 
cleaved protein was collected in 1 ml fractions by washing through with buffer 
containing 150mM NaCl, 50mM HEPES, pH 7.0.
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3.1 Introduction
Bovine PrxIII was cloned previously in our laboratory (Gourlay et aL, 2003); 
however PrxIII requires its cognate partners, mammalian mitochondrial thioredoxin 
(Trx2) and mammalian mitochondrial thioredoxin reductase (TRR2), to 
reconstitute the complete antioxidant defence pathway. To establish a direct in 
vitro assay for PrxIII, Trx2 and TRR2 were cloned, overexpressed and purified. 
The successful cloning of recombinant human Trx2 and the crystal structure of 
Trx2 was published veiy recently (Smeets et al., 2005) but no successful cloning, 
expression and purification of active recombinant of TRR2 has been reported to 
date.
The pET (plasmid for expression by T7 RNA polymerase) system vectors were
chosen to produce Trx2 and TRR2 as N-terminally His-tagged proteins. This
system enables high-level expression of cloned genes in E. coli and is presently the
preferred choice of prokaryotic system for heterologous expression. The 
.bacteriophage T7 RNA polymerase is integrated into the bacterial genome in the E. 
coli BL21 expression strain and its cognate promoter on the pET vector tightly
controls heterologous protein production from the pET plasmid. Expression of T7 
RNA polymerase is induced in E. coll BL21 (DE3) pLysS cells on addition of 
IPTG.
As described in the first chapter, TRR2 contains the C-terminal active site motif 
Gly-Cys-SeCys-Gly in which the SeCys is encoded by UGA, normally a ‘stop’ 
codon and so requires the presence of a SECIS for correct translation. However, the 
SBCIS of mammalian selenoproteins has different secondary structural 
characteristics and conserved features than in E. coli (Fig 3.1 a). Moreover, the 
mammalian SECIS is often situated in the 3’-untranslated region several hundred 
nucleotides downstream of the UGA codon (Low and Berry, 1996). Thus 
mammalian selenoprotein genes are unsuitable for direct recombinant expression in 
E. coli. A technique, however, to by-pass the barriers to heterologous expression of 
mammalian selenoproteins in bacteria was employed by mimicking the mechanism 
used in E. coli formate dehydrogenase H (Fig 3.1 b).
The complex translational machinery for expression of bacterial selenoproteins 
such as formate dehydrogenase H was reviewed by Bock et a l  (1991) and 
Stadtman (1996). The mRNA for this selenoprotein contains a SECIS about 40 
nucleotides long and positioned immediately after the UGA codon. These 
nucleotides have dual functions; they provide codons for translation of amino acids 
following the selenocysteine residue, in this case a glycine residue, and they fold 
into a stem-loop secondary structure. The stem-loop SECIS binds the SELB 
protein, the product of the selB gene. SELB is homologous to elongation factor EF- 
Tu but, in addition, carries a carboxy terminal domain interacting with the loop 
region of the SECIS. SELB also binds to a selenocysteine-specific tRNA 
(tRNASec), the selC gene product, in its selenocysteinylated form. Thereafter, by 
analogy with EF-Tu, SELB is positioned on the ribosome catalyzing selenocysteine 
insertion at the specific position of the selenocysteine UGA codon. Taken together, 
selenocysteine insertion during selenoprotein translation in E. coli involves an E. 
co//-type SECIS just following the UGA codon in the selenoprotein mRNA, and 
the selA (encoding selenocysteine synthase), sc IB and selC gene products.
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Figure 3.1 Selenocysteine insertion sequence (SECIS)
a) Predicted secondaiy structure of the SECIS at the 3-UTR region of human 
TRR2; b) formate dehydrogenase H SECIS of E, coli
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Adding the entire SECIS of E. coli presents difficulties for standard PCR insertion 
procedures. Therefore, a minimal SECIS capable of forming the secondary
stmcture loop was designed and incoiporated into the PCR primers. The loop 
region of the SECIS is the SelB binding site and is base specific whereas the stem 
region is length specific but not base specific requiring at least 11 nucleotides
downstream of the Sec UGA codon (Arner et a l, 1999). Overall, there are 13 
matched bases and 30 unmatched bases in the 3’ primer.
3.2 Results
3.2.1 Primers for Trx2
Human Trx2
Forward: GAGGATGGATCCGACAACCTTTAATATCCAGG
Reverse: CATCCCGGATCCTCAGCCAATCAGCTTCTTC
Figure 3.2 Oligonucleotide primers for Ti-x2 clone
Bamlil site is underlined.
3.2.2 PCR Amplification of Human Ti*x2
The PCR template for the human Trx2 gene was IMAGE clone 5588243, obtained 
from Geneservice Ltd. A standard PCR method was performed to amplify the gene 
from the initial template. In order to use the pET-14b vector, it was necessary to 
incorporate an extra base immediately before the start codon of the inserted gene to 
give the correct reading frame. BamHl restriction sites were incorporated into the 
primers so that the amplified gene product could be incorporated into the pET-14b 
vector (Fig 3.2). All primers terminated with either a guanine or cytosine 
nucleotide to reduce the occurrence of base mismatches. To minimise errors in 
base incorporation, the Pfu DNA polymerase was used in the PCR reaction. Pfu is 
a magnesium-dependent, thermostable enzyme with 3’-> 5’ exonuclease 
proofreading activity.
PCR products were gel-purified and analysed on a 1% (w/v) agarose gel, alongside 
a Ikb DNA Step Ladder (Materials and Methods, section 2.2.3). A band of ~320bp 
was observed, corresponding to the expected size of the human Trx2.
■|
The purified Trx2 insert gene and pET-14b vector were treated with BamHl to 
generate cohesive ends. To prevent pET-14b self-ligation, 5’-phosphates were 
removed by adding 1 unit of calf intestine alkaline phosphatase (CIAP) for 30 min 
before the end of digestion.
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3.2.3 Ligation
Different ratios (1:1, 1:3 and 1:7) of vector to insert were added together and a 
control ligation with vector only was used to determine the efficiency of the 
dephosphoiylation step. Ligated plasmid was then transfomied into E. coli DH5a 
cells. Colonies were not seen on the control plate. Six clones were selected to grow 
a series of 5ml overnight cultures. Plasmid minipreps were performed next day 
from the 5ml overnight cultures. Purified DNA was either sent for sequencing or 
subjected to PCR analysis.
A set of 2 parallel PCR reactions was performed. One set used the T7 promoter 
primer and Trx2 reverse primer while the other uses the T7 terminator primer and 
Trx2 forward primer. An example of a positive result, in which the correct size of 
PCR product is observed on the gel with the T7 promoter primer and Trx2 reverse 
primer of the target insert, shows successful ligation in the correct orientation (Fig
3.3 lane IR).
Purified positive plasmids were transformed into E. coli BL21(DE3) pLysS cell for 
protein expression.
3.2.4 DNA sequencing
Overnight cultures (5ml) were harvested and sent for DNA sequencing. The 
sequencing was performed on a MegaBACElOOO instrument in the Sir Henry 
Wellcome Functional Genomics Facility (SHWFGF), University of Glasgow. 
Typically there were 400-600 bases with good signal from each sequence run. 
Sequencing from both ends of the insert was performed routinely.
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Figure 3.3 PCR check of putative Trx2 clones
Following PCR amplification o f Trx2 from the Trx2/pET-14b template, 5 pi was 
analysed on a 1% (w/v) agarose gel. Bands were stained with ethidium bromide, and 
sizes were determined by comparison with a Ikb DNA Step Ladder (M), shown to 
the right o f the gel, with units in base pairs (bps). Two parallel PCR reactions were 
performed for each clone. The T7 terminator primer and Trx2 forward primer were 
used as a pair o f primers for one PCR (marked as F in the figure) while the T7 
promoter primer and Trx2 reverse primer were used as the other pair o f primers for 
the other PCR (marked as R in the figure). A typical agarose gel o f the PCR results 
from 3 clones (1,2,3) is shown in this figure. Arrow indicates the PCR products. In 
this gel, clone 1 shows a PCR product with T7 promoter primer and Trx2 reverse 
primer which indicates the presence o f insert in the correct orientation in contrast to 
clone 3 where the insert is in the opposite orientation.
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3.2.5 Protein Expression of Trx2
E. coli BL21 (DE3) pLysS cells with the Ti-x2 gene were grown to log phase before 
IPTG was added. To confirm the correct orientation of the Trx2 insert gene, both 
clones 1 and 3 shown in the previous gel were induced. Following reducing SDS- 
PAGE, a band at 17 kDa was observed, corresponding to the predicted Mr value of 
Trx2 together with its N-terminal His-tag. Clone 1, which is the positive clone, ■ ;produced this band after induction (Fig 3.4); however, as expected, clone 3 did not
3.2.6 Protein solubility and purification
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give a similar product.
Bacterial cell lysis was performed as described in Material and Methods section 
2.2.10. Trx2 was found in the supernatant fraction but not in the pellet as visualized 
on SDS-PAGE analysis (data not shown), indicating that Trx2 was soluble under 
these conditions. Soluble protein from large-scale (500ml) bacterial cultures was 
then purified by Zn^ "*' chelate affinity chromatography using a BioCAD® 
70OE™Workstation. Samples from peak fractions were analysed by SDS-PAGE to 
assess sample purity (Fig 3.5).
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Figure 3.4 Overexpression of Trx2
Trx2 were overexpressed at 37°C in BL21(DE3)pLysS cells, by induction 
with ImM IPTG. Samples (1ml) were removed at the point o f induction 
(Oh) and after 3 hours (3h). Bacterial pellets were resuspended in Laemmli 
sample buffer ( 1 Opl/0.1 ODôoo o f original culture), and denatured for 5 min 
at 100°C in the presence o f DTT (150mM). Samples were analysed on a 
10% SDS/polyacrylamide gel, and stained with Coomassie Brilliant Blue. 
The expression o f Trx2 from the clones analysed in the previous section 
(clones 1 and 3) is shown in the lanes indicated. Molecular weight markers 
(M) are shown to the left o f the gel.
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Figure 3.6 BioCAD fractions of purified Trx2
A sample (lOp-1) from the peak fraction was diluted with an equal volume of 
Laemmli sample buffer, supplemented with DTT (150mM) and denatured for 5 
min at 100°C, prior to loading on a 10% SDS/polyacrylamide gel. Bands were 
stained with Coomassie Brilliant Blue. Molecular weight markers (M) are shown 
to the left of the gel.
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3.2,7 Estimation of accessible reactive cysteines in pnrified Trx2
Ellman’s assay was used to confirm the number of reduced cysteines in purified 
Trx2 that were accessible to thiol modification by the reactant 5,5’- 
dithionitrobenzoic acid (DTNB). The number of thiols accessible to DTNB was 
assessed by measuring the A412 of the nitrothiobenzoate (NTB) product released 
during the reaction. Purified Trx was reduced by lOmM DTT and passed through a 
PD-10 desalting column to remove excess DTT. The A412 of reduced Trx was 
measured over two weeks using the DTNB assay as described in Materials and 
Methods, section 2.4.9 (Fig 3.6). Two cysteines were accessible initially but they 
gradually lost their ability to reduce DTNB after 2 weeks. This implies there are 2 
free cysteines as expected but they are reoxidised over a 2 -week period in the 
absence of reducing agent during storage at 4"^ C.
No. of 
free
cysteines
2
2 4 8 I D $12 14
□ays
Figure 3.7 Reoxidization of Trx2 in solution as monitored by loss 
of reactivity with DTNB
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3.2.8 Cloning of TRR2
TRR2 was cloned using a similar strategy to Trx2 from IMAGE clone 5554051, 
purchased from Geneservice Ltd. A band of -1,500 bp was observed after PCR 
amplification, corresponding to the expected size of the human TRR2 (Fig 3.8). 
PCR products were then ligated into the pET-14b vector via its unique BamHl site. 
However, for this unusual SeCys protein, the presence of a SECIS is important for
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. I fISeCys incorporation for TRR2 to have activity. SECIS was introduced by designing C-terminal primers so that the adjacent 3’ untranslated sequence 
contained the required sequence elements (Fig 3.7).
3.2.9 Primers
Human TRR2 without SECIS
Forward: CGCAGCGGATCCTCAGCGGGACTATGATCTCC
Reverse: CAGGGAGGATCCTTACCCTCAGCAGCC
Human TRR2 with SECIS
Forward: CATATGGATCCTCAGCGGGACTATGATCTC C
Reverse: GAGGATCCGGTGCAGACCTGCAACCGATTATTACCCTCAGCAG
Figure 3.7 Oligonucleotide primers for TRR2 clone
The BamHl site is underlined. The loop region of SECIS is highlighted in blue. The 
double stop codon is highlighted in red. The SeCys UGA codon is highlighted in 
plum.
Unlike Trx2, the solubility of TRR2 under standard expression conditions was veiy 
poor. As shown in Fig 3.9, although the expression at 22°C was much better than at 
15°C, the majority of the TRR2 was still insoluble. By optimizing various 
parameters, the best conditions for maximal TRR2 yield and solubility involved 
growth in a modified rich LB media (Material and Methods, section 2.1.6) and 
appropriate antibiotics. Cells were induced by 0.3mM IPTG at 15°C for 18h at a 
starting ODgoo of 0.5. NaiSeO] (1 p.M) was added as a supplement when cultures 
were induced. Cells were then lysed by French Press treatment in high-salt buffer 
(0.5mM imidazole, l.OM NaCl, 20mM HEPES pH 8.0). T
Two peaks emerged from the metal chelate column during the elution step. 
SDS-PAGE gel analysis shows that peak 2 corresponds to the target protein (Fig 
3.10). The purified enzyme was yellow in colour and showed significant 
absorbance at 450nm indicating the incorporation of the FAD cofactor. 
Approximately 4-5 mg soluble protein could be purified per litre of original 
culture. Peak 1 contained a single unidentified protein which exhibited no TRR2 
activity.
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Figure 3.8 PCR check of recombinant TRR2 pET14b plasmid
Following PCR amplification of TRR2 from the TRR2/pET-14b template, the 
product (5pi) was analysed on a 1% (w/v) agarose gel. Bands were stained with 
ethidium bromide, and sizes were determined by comparison with a Ikb DNA Step 
Ladder (M), shown to the right of the gel, with units in base pairs (bp). Three 
templates were used ( 1,2,3). T7 terminator primer and TRR2 forward primer were 
used as a pair of primers for one PCR (R) while T7 promoter primer and TRR2 
reverse primer were used as a pair of primers for the other PCR (F). Arrows 
indicate the PCR products. Both clones 1 and 3 show a PCR product with T7 
promoter primer and TRR2 reverse primer which indicates the presence of insert 
in the correct orientation.
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Figure 3.9 Assessment of TRR2 expression and solubility
TRR2 overexpression was attempted at different temperatures in E. coli 
BL21(DE3)pLysS cells, by induction with 0.3mM IPTG. Samples (1ml) were 
removed at the point of induction (Oh). Samples from overnight (O/N) induction 
at 15°C and 5 hours (5h) at 22°C induction were also removed. After induction, 
the bacterial culture (500ml) was centrifuged and the pellet resuspended in 20ml 
20mM HEPES buffer, pH 8.0 containing IM NaCl. Cells were lysed by two 
passages through a French Pressure Cell at a pressure of 950Psi. The cell extract 
was separated into its soluble (S/N), and insoluble (P) fractions by 
centrifugation. All samples were diluted with an equal volume of Laemmli 
sample buffer, supplemented with DTT (150mM) and denatured for 5 min at 
100°C, prior to loading on a 10% SDS/polyacrylamide gel. Bands were stained 
with Coomassie Brilliant Blue. Molecular weight markers (M) are shown to the 
right of the gel.
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Figure 3.11 BioCAD fractions of purified TRR2
Sample (lOpl) from the 2 peak fractions were withdrawn and diluted with an 
equal volume of Laemmli sample buffer, supplemented with DTT (150mM) 
and denatured for 5 min at 100°C, prior to loading on a 10% 
SDS/polyacrylamide gel. Bands were stained with Coomassie Brilliant Blue. 
Molecular weight markers (M) are shown to the left of the gel.
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3.2.10 Catalytic activity of TRR2
Measurement of DTNB reductase activity was performed at 25°C in freshly 
prepared 100 mM Tris-HCl, pH 7.5, 2 mM EDTA. TRR2 (1 pg) and 1.5 mM 
DTNB was also added. The reaction was initiated by adding 0.2 mM NADPH. 
Absorbance is read at 412 nm and the activity is expressed as pmol/min/mg protein 
and can be calculated by AA4i2xl000/(13.6 x 2)/min.
3.2.11 Optimization of the TRR2 activity
To screen for the highest activity of TRR2, different constructs were made and 
analyzed, including the pET and pQE expression systems. The TRR2 sequence and 
the SECIS were amplified by PCR and ligated into the pQE31 vector via the 
BamHl site as described previously for pET-14b. The TRR2/pQE31 plasmid was 
then transformed into E. coli MIS cells for maximum overexpression. To increase 
the efficiency of selenoprotein production, a plasmid carrying the selABC genes 
(generously gifted by E.S. Arner) was also co-expressed. A construct without 
SECIS was employed as the negative control. Data from native TRRl isolated from 
rat liver was included as positive control data (Bar-Noy, 2001).
Constructs Specific activity of TRR2 
(pmol/rain/mg protein)
pET vector without SECIS 0.14
pET vector with selABC plasmid 2.2
pQE vector without selABC plasmid 3.2
pQE vector with selABC plasmid 4.2
Native isolated rat liver TRRl 40-50
Table 3.1 Specific activities of purified recombinant human TRR2 expressed 
from different constructs
By comparing the catalytic activities of purified human TRR2 produced from 
different constructs, it is clear that the SECIS is very important in improving
63
a;
■|
%■
;;;
t$
III
4.
recombinant TRR2 activity. Constructs with SECIS showed 15-30 fold more 
activity than the control enzyme with the pQE vector system performing better than 
the pET system. Sui*prisingly, the inclusion of the selABC plasmid did not promote 
significant improvement in TRR2 specific activity. In addition, the most active 
recombinant TRR2 only attained approx. 10% of the specific activity of native rat 
liver TRRl which is in line with reported literature values obtained for 
recombinant forms of TRRl (Amer et a l, 1999).
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3.3 Discussion
3.3.1 Checking of recombinant clones
Here, a method was employed using PCR analysis, which is quick and convenient 
involving only 2h for a standard PCR and gel running time. No specific enzymes 
are employed, as only the original primers employed in the cloning procedure plus 
T7 promoter primer and terminator primer are necessaiy and therefore independent 
of insert sequence. Positive clones from the PCR check were all sent for DNA 
sequencing to verify the accuracy of the amplified sequence and its correct 
insertion in frame.
3.3.2 Expression of heterologous proteins
For producing recombinant soluble proteins, E. coli is still the organism of choice 
in most cases. It produces large biomass, is very cheap to grow, and the equipment 
needed to culture and harvest E. coli is easy to obtain. Unfortunately, E. coli are not 
particularly amenable hosts for many human proteins. Expression of large proteins 
(>60 kDa) is often difficult, and toxicity and solubility remain huge obstacles. 
Some alterations in the conditions of expression can help reduce the solubility 
problem. Lowering the temperature at induction to 16°C-25°C has been extremely 
helpful in increasing solubility. Other possible solutions include E. coli strain
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To ensure successful ligation of the required insert a digestion of the recombinant 
plasmid was performed with the restriction enzymes employed for the original 
ligation. In addition, if the insert has been ligated non-directionally at a single 
restriction site, as in this case, then an orientation check is also necessary. 
Traditionally, to achieve this, restriction endonucleases are chosen which will cut 
both within the insert and also the vector, thereby producing predicted fragment 
sizes that differ with orientation. By judging the fragment sizes from the agarose 
gel, a conclusion can be made on the orientation. However, this traditional method 
has some limitations as suitable restriction endonucleases need to be found to cut 
both the insert and vector and give different results for different orientations. To 
achieve this is not always possible or the most convenient restriction enzyme is 
expensive or not readily available.
I
choice, co-expression of chaperones, and the inclusion of additives in the media. 
However, so far there is no routine and reliable route to achieve high-level 
expression of all soluble heterologous proteins so optimal conditions must be 
determined on a case by case basis.
3,3.3 Overexpression of soluble active recombinant TRR2 in E. coli
Previously, in the absence of soluble recombinant TRR2, PrxIII activity had to be 
measured by an indirect method, in which PrxIII activity was determined in vitro 
by assessing its protective effect towards enolase in the presence of a metal- 
catalysed free-radical generating system (Gourlay et a l, 2003). Quantitative 
comparison of the activity of various PrxIII mutants is extremely difficult to assess 
by this indirect approach. Thus successful cloning, overexpression and purification 
of TRR2 and Trx2 is crucial for further structure-function studies of PrxIII and its 
reconstituted antioxidant pathway.
The C-terminal primer for amplification of TRR2 was designed to incorporate the 
correct SECIS for the translation of its penultimate SeCys codon. An additional 11 
nucleotides were included between the UGA codon and the sequence-specific loop 
region. A double stop codon was also added which was shown to give a higher 
specific activity for TRRl (Arner et a l, 1999).
Standard protocols, such as 3h at 37°C, for overexpression of TRR2 yielded only 
insoluble protein. Overexpression at 22°C and 15°C was tried as was protein 
refolding after solubilisation of inclusion bodies in 8M urea. Only insoluble 
aggregate protein was obtained by these approaches. Different growth media and 
lysis buffers were tried and a low concentration (0.3mM instead of ImM) of IPTG 
was added to give a slower rate of overexpression. A 42°C heat shock step before 
induction was also performed to produce endogenous chaperones as an aid to 
protein folding. However, none of the above methods were successful in improving 
TRR2 solubility. The reasons for the failure of these approaches could be:
a) TRR2 is a relatively large (55kDa) protein which exceeds the protein mass 
limitation of the E. coli system, thereby requiring a very slow 
overexpression to give maximum time for correct protein folding.
66
b) TRR2 is a SeCys protein. Translating SeCys proteins in E. coli is a complex 
event. It needs the SECIS, tRNA for the SeCys, a supply of selenium and 
elongation factors.
The optimal solution for the successful overexpression of active TRR2 proved to 
be a combination of different approaches. Overexpression at 15*^ C in the presence 
of low IPTG concentration in a modified rich LB media gave good overexpression 
of soluble enzyme. Moreover the addition of the SECIS at the C-terminal of the 
insert, in the presence of 1 p,M NaiSeO] and co-expression of the SelABC plasmid 
ensured an optimal supply of the relevant tRNA, tRNA synthase and recognition 
factor for translation of the UGA SeCys codon.
After achieving successful expression and purification of soluble, active His-tagged 
TRR2, an additional affinity purification step was attempted employing a 3’-5’- 
ADP Sepharose column using the NADPH binding capacity of the enzyme. 
However, this step was abandoned for two reasons. Firstly, there was no increase in 
specific activity by comparing the results from activity assays. Secondly, this 
additional affinity purification step resulted in a significant decrease in the yield of 
TRR2.
■I:
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Chapter 4
68
Assays
4.1 Introduction
To date, the activity of PrxIII has only been determined indirectly in vitro by 
assessing its protective effect towards enolase in the presence of a metal-catalysed 
free-radical generating system (Gourlay et al., 2003). After successful cloning, 
overexpression and purification of PrxIII, Trx2 and TRR2, the PrxIII pathway was 
reconstituted and studied in vitro in this chapter. NADPH oxidation was monitored 
coupled to H2O2 reduction by TRR2, Trx2 and Pi-xIII (Fig 4.1). NADPH has an 
absorbance peak at 340nm that is absent in NADP^; therefore the oxidation of 
NADPH can be monitored to assess the activity of the PrxIII pathway and various 
mutants.
NADP+ Trx2-S,
TRR2
PrxfH ox H 2O 2
► H ;0N A D PH — ' ’"Trx2-(SH)2 '^ > P rx Illu tD
Figure 4.1 The PrxIII mitochondrial aiitioxidaiit defence pathway
A unique property of mammalian peroxiredoxins is their sensitivity to 
overoxidation in the presence of elevated levels of H2O2 . PrxIII sensitivity in this 
case is examined both by the H2O2 concentration dependence of the pathway and 
the appearance of abnomial oxidised forms of PrxIII on SDS-PAGE analysis.
Recently, TEM (transmission electron microscopy) and studies of the crystal 
structure of several typical 2-Cys Prxs have revealed two distinct oligomeric forms: 
dimer and decamer. While the rat haem binding protein HBP23 has just one 
dimeric form (Hirotsu et al., 1999), some other members like tryparedoxin 
peroxidase (TryP) from Crithidia fasiculata (Alphey et a l, 2000), thioredoxin 
peroxidase B (TPx-B) from human eiythrocytes (Schroder et a l, 2000) and alkyl 
hydroperoxidase C (AhpC) from Salmonella typhimurium (Wood et a l, 2002) can 
exist as dimers or decamers. The factors that govern oligomeric assembly are not 
well understood. Fligh or low ionic strength and low pH have been reported as key
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factors (Kitano et a l, 1999; Kristensen et a l, 1999; Chauhan and Mande, 2001) 
and more importantly, oligomerization has been shown to be redox sensitive, with 
the reduced enzyme strongly favouring the decameric form and oxidation 
favouring dissociation into dimers (Wood e ta l, 2002).
In this chapter, gel filtration chromatography (GFC) was employed for assessment 
of the overall molecular weight and oligomeric state of PrxIII. This technique is 
especially useful for monitoring alterations in the quaternaiy structure of a protein 
over a wide variety of conditions including pH, temperature and ionic strength. In 
gel filtration, the stationaiy phase consists of porous beads with a well-defined 
range of pore sizes. Proteins that are small enough can fit inside all the pores in the 
beads and are said to be included. These small proteins have access to the mobile 
phase inside the beads as well as the mobile phase between beads and elute last in a 
gel filtration separation. Proteins that are too large to fit inside any of the pores are 
excluded and are eluted at the void volume (Vo) of the column which is approx. 
30% of the total column volume. They have access only to the mobile phase 
between the beads and, therefore, elute first. Proteins of intermediate size are 
partially included and gain access to some but not all of the pores in the beads. 
These proteins will then elute between the large ("excluded") and small ("totally 
included") proteins. Therefore, GFC is a simple and reliable chromatographic 
method for separating native proteins according to size.
The approx. size of a globular protein of interest is determined by comparing the 
ratio of the elution volume (Vc) to the void volume (Vo) for the unknown protein. 
The void volume is based on the elution volume of a large macromolecule usually 
for the pre-packed HiPrep 16/60 Sephaciyl S-300 column with a Mr of 2 x 10  ^or 
greater. A calibration curve is generated using the logarithms of the known 
molecular weights of the protein standards, against their respective Vc/Vo values. 
From this calibration curve the apparent Mr value of the protein under investigation 
can be determined.
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4.2 Results
4.2.1 Reconstitution of the PrxIII pathway
Assay o f PrxIII pathway activity was performed by measuring the disappearance of 
NADPH when H2O2 was added to the reaction. A 1 ml assay mix containing 50 
mM Tris-HCl, pH 7.5, 100 pM NADPH, 2 pM Trx2, 1 pM TRR2 and 5 \xM PrxIII 
was incubated at 25 °C. The reaction was initiated by adding 0.2 mM H2O2 . 
Controls omitting each component o f the pathway, in turn, were also carried out. 
The A 340 were recorded by using an Ultrospec 4300 pro UV/Visible 
spectrophotometer over 180 s to monitor the oxidation o f NADPH as the reducing 
substrate donor (Fig 4.2).
A A340
0 . 1
0. 08
0. 06
0. 0 4
0 . 02
TRR2 - + + +
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Figure 4.2 NADPH oxidation coupled to H 2O 2 reduction by various 
combinations of TRR2, Trx2 and PrxIII
NADPH oxidation was monitored at 340nm in a 1ml reaction mixture containing 
50 mM Tris-HCl, pH 7.5, 100 pM NADPH and the indicated combinations o f 2 
pM Trx, 1 pM TRR, 5 pM PrxIII and O.lmM H2O2 . All reactions were performed 
in triplicate.
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4.2.2 Broad substrate specificity of Prxlll
Employing the reconstituted PrxIII pathway, the substrate specificity of PrxIII was 
assessed using two readily available organic hydroperoxides, cumene peroxide and 
t-butyl peroxide. A340 was monitored as an indication of the PrxIII activity and 
compared to its activity with its natural H2O2 substrate (Fig 4.3). The figure shows 
PrxIII has less ability to reduce organic hydroperoxides under these conditions, t- 
Butyl peroxide promotes about 80% and cumene peroxide promotes about 40% of 
control activity with H2O2 as substrate.
A ctiv ity%
100
8 0
6 0
4 0
20
0
H 2 O 2 Cumene peroxide t-Butyl peroxide
Figure 4.3 Relative activity o f PrxIII with organic hydroperoxides as 
substrate
NADPH oxidation was monitored at 340nm in a 1ml reaction mixture 
containing 50 mM Tris-HCl, pH 7.5, 100 pM NADPH and the indicated 
combinations of 2 pM Trx, 1 pM TRR, 5 pM PrxIII and O.lmM peroxide 
substrate. The activity of PrxIII coupled with H2O2 was used as the reference 
which has 100% activity. All reactions were performed in triplicate.
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4.2.3 Effect of H2O2 concentration on overall PrxIII pathway activity
To examine the substrate concentration dependence of the PrxIII pathway, different 
concentrations of H2O2 were added into the PrxIII assay (Fig 4.4). At the lowest 
H2O2 concentration shown (20 pM), maximal rates of reaction were already 
achieved which showed that Pi-xIII displayed a very high affinity for its peroxide 
substrate. In the range 20 pM to 250 pM H2O2 , the PrxIII pathway exhibited 
constant activity. However, at high levels of H2O2 (500 pM-10 mM), there was a 
progressive decline in overall activity, probably caused by the overoxidation of the 
active site cysteines of PrxIII (see Fig 4.5).
Maximal rates of reaction with 5 and 10 pM of H2O2 were also observed but not 
presented owing to the rapid termination of the reaction resulting from exhaustion 
of the substrate.
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Figure 4.4 Time course of PrxIII dependent NADPH oxidation coupled to 
H2O2 reduction
NADPH oxidation was monitored at 340nm in a 1ml reaction mixture containing 
50 mM Tris-HCl, pH 7.5, 100 pM NADPH, 2 pM Trx, 1 pM TRR, 5 pM PrxIII 
and different H2O2 concentrations as indicated.
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4.2.4 Analysis of the oxidation-reduction state of PrxIII
I
Recombinant PrxIII has a subunit Mr of 25,000; however, in its oxidised state, it 
appears as a homodimer on SDS-PAGE (-DTT) owing to intersubunit disulphide 
bond formation between its N and C terminal cysteines. This property of PrxIII was 
exploited to monitor its change in oxidation state after treatment with increasing 
levels of H2O2 .
Initially, purified PrxIII was reduced by DTT, and excess DTT removed on a 
Sephadex PD-10 desalting column. Different concentrations (from 0.05pM to IM 
H2O2) were mixed with 1 pM PrxIII at room temperature for 10 min. Then samples 
were diluted with an equal volume of Laemmli sample buffer and denatured for 5 
min at room temperature, prior to resolving on a 12% SDS/polyacrylamide gel. 
Bands were stained with Coomassie Brilliant Blue. As PrxIII was fully reduced by 
DTT, at very low H2O2 concentration only monomer (25kDa) (band a in Fig 4.6) 
was observed on SDS-PAGE analysis (lane 1 in Fig 4.5). With increasing H2O2 
concentration, more PrxIII is oxidized to form dimers (band b) or partial dimers 
with a higher M,- (50 kDa) (lanes 2-4). Complete conversion of monomer (reduced) 
to dimer (oxidised) PrxIII is achieved with 10 pM H2 O2 (lane 4) confirming the 
high affinity of PrxIII for its natural substrate. At higher H2O2 levels, a more 
extended band of lower mobility than the normal dimer became increasingly 
apparent (lanes 5-9). This band may represent a partially overoxidized form of 
PrxIII (band c). At very high H2O2 concentrations, a monomer band (band d) is 
also evident (lanes 7-9) suggesting the presence of highly oxidised PrxIII that is 
incapable of dimer fonnation,
A scheme for the possible oxidation states of PrxIII detected by their differing gel 
mobility is depicted in Fig 4.6.
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Figure 4.5 P rx lll oxidation by hydrogen peroxide
Non-reducing SDS-PAGE analysis of PrxIII (17.5pM) oxidation by H2O2 at the 
following concentrations: lane 1, 0.5pM; lane 2, IpM; lane 3, 5pM; lane 4, lOpM; 
lane 5, 50 pM; lane 6, lOOpM; lane 7, 0.5mM; lane 8, ImM; lane 9, lOmM. The 
possible identities of bands a, b, c and d are described in Fig 4.6. The apparent 
heterogeneity of the monomer bands is probably caused by aberrant formation of 
intra-subunit disuphide bonds in the highly oxidising conditions of the gel.
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Figure 4.6 Proposed oxidation-reduction states o f P r x lll  produced by 
increasing concentrations of H2O 2
Possible formation of different oxidation-reduction states of PrxIII. a) reduced 
form of PrxIII. b) oxidized form of Prxlll with two disulphide bonds forming 
between two adjacent subunit at relatively low H2O2 concentration, c) partially 
overoxidized (more extended) form of PrxIII at high H2O2 concentration which 
shows a dimer band of lower mobility than the normal oxidised form, d) totally 
overoxidized form of PrxIII at very high concentrations of H2O2 . In the absence 
of reduced sulphydryl groups, dimer formation is prevented and monomer PrxIII 
is again observed on the gel. Other forms in which the sulphur is present as a 
sulphenic acid RSOH arc of course possible.
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4.2.5 A ctivity  o f the P r x lll  pathw ay over a w ide range o f H2O 2 
concentrations
To examine if  PrxIII can be completely overoxidised and therefore inactivated by 
H2O2, a wider range o f H2O2 concentrations was tested in the PrxIII assay (Fig 4.7).
At very low H2O2 concentration (20|xM), the PrxIII pathway reaches maximal 
activity. However, overall activity gradually decreased in the range o f 50pM - 
lOmM H2O2 predicted by the susceptibility o f PrxIII to overoxidation.
Surprisingly, instead o f declining to zero at higher H2O2 levels, a second burst o f  
NADPH oxidation occurred, peaking at lOOmM substrate, which is much higher 
than the physiological range. Complete inactivation required IM H2O2 .
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Figure 4.7 Profile of P rx lll pathway activity at different H 202  concentrations
NADPH oxidation was monitored at 340nm in a 1ml reaction mixture containing 
50 mM Tris-HCl, pH 7.5, 100 pM NADPH, 2 pM Trx, 1 pM TRR, 5 pM PrxIII 
and different H2O2 concentrations. The linear decrease o f  A 340 over 180s against 
the log 10 o f H2O2 concentration is shown.
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To investigate the reason for this unusual activity profile, different combinations of 
pathway components were checked. It was discovered that TRR2 alone can reduce 
H2O2 directly at high substrate concentrations but makes no contribution at low 
H2O2 levels (Fig 4.8).
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Figure 4.8 Overoxidation study of P rx lll at different H2O 2 concentrations
NADPH oxidation was monitored at 340nm in a 1ml reaction mixture containing 
(red line) of 50 mM Tris-HCl, pH 7.5, 100 pM NADPH, and 1 pM TRR, and 
(black line) of 50 mM Tris-HCl, pH 7.5, 100 pM NADPH, 2 pM Trx, 1 pM TRR, 
5 pM PrxIII and different H2O2 concentrations. The decrease in A340 over 180s 
against the log of H2O2 concentration is shown.
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4.2.6 Role of the Conserved Cysteines in P rx lll Peroxidase Activity
To assess the role of the conserved cysteine residues in the catalytic activity of 
Prxlll, the Prxlll pathway assay was repeated for the cysteine mutants (Fig 4.9).
C47S and C168S show no activity as did the control which had no H2O2 added. 
C66S shows very similar activity to the wild-type enzyme. These results confirm 
the role of cysteine 47 and 168 in catalysis, and also indicate that the non­
conserved Cys 66 is not essential for enzyme activity.
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Figure 4.9 Time course o f P rx lll dependent NADPH oxidation coupled to 
H2O 2 reduction for various cys mutants of P rx lll
NADPH oxidation was monitored at 340nm in a 1ml reaction mixture containing 
50 mM Tris-HCl, pH 7.5, 100 pM NADPH, 2 pM Trx, 1 pM TRR, O.lmM H2O2 
and 5 pM of various Prxlll mutants. Reaction without H2O2 (green line) was used 
as the negative control. Reaction with wild type Prxlll (black line) was used as 
positive control.
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4.2.7 Gel filtration analysis of the oligomeric state of PrxIII
Gel filtration chromatography (GFC) was used to study the oligomeric state of 
Prxlll under various conditions (Fig 4.10).
His-tagged PrxIII, purified by MC chromatography, was buffer exchanged into 
25mM HEPES pH 7.2, 50 mM NaCl, 5mM EDTA buffer and run through a 
Sephacryl S-300 gel filtration column (Material and Methods section 2.4.7). 
Fractions (1ml) were collected and analysed by SDS-PAGE to confirm that the 
peaks represented the target protein. Vc was determined from monodisperse, 
symmetrical peaks.
Previous studies in our laboratory have shown that PrxIII exists as a stable 
oligomeric toroid with an apparent M,- value of 450-500 kDa. The oligomeric state 
of PrxIII was found to be independent of changes in influence of pH in the range 5- 
9 or ionic strength (0-2M NaCl). Therefore, in this study, the redox state, protein 
concentration and the presence of the His-tag on the stability of the PrxIII oligomer 
was tested as shown in Fig 4.10. Removal of the His-tag from oxidised PrxIII 
caused its complete dissociation into a low Mr value, 50 kDa dimeric fonn at low 
protein concentration (1 mg/ml) whereas at higher levels (lOmg/ml), a mixture of 
high Mr (dodecamer) and dimeric forms was present. In contrast, His tagged PrxIII 
existed exclusively in its high Mr oligomeric state even at low protein 
concentration. Reduced PrxIII was present as oligomeric toroids regardless of 
protein concentration and the presence or absence of the His-tag.
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Figure 4.10 Gel Filtration Chromatography (GFC) elution profile for P rx lll
GFC analyses were used to determine the oligomeric state of Prxlll. Blue lines 
represent protein without His-tag. Red lines represent protein with His-tag.
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4.3 Discussion
By completing the cloning, overexpression and purification of PrxIII, Trx2 and 
TRR2, it has been possible to reconstitute the entire mitochondrial PrxIII 
antioxidant defence pathway in vitro. To develop the optimal conditions for 
determination of pathway activity, different concentrations of pathway components 
were varied independently in the reconstituted pathway assay to achieve a situation 
where PrxIII levels were rate limiting to the overall reaction. A relatively high 
concentration of TRR2 was required, presumably reflecting the low specific 
activity of the recombinant enzyme compared to its wild-type counterpart. 
However, as TRR2 also has the capacity to reduce H2O2 directly in an NADPH- 
dependent manner, care was also taken to ensure that this secondary reaction did 
not interfere with direct measurement of the activity of the complete antioxidant 
defence pathway.
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The results show, particularly at low H2O2 concentrations in the physiological 
range, that the presence of all three pathway components is essential for 
reconstitution of activity. At high H2O2 concentrations in the non-physiological 
range, the N ADPH - dependent TRR2 can reduced H2O2 directly, presumably by 
leakage of electrons from its flavin rings. Another mitochondrial member of the 
pyridine nucleotide family of oxidreductase family, dihydrolipoamide 
dehydrogenase, is also reported to have an NADH oxidase activity in which 
electrons are transformed from the edge of the flavin ring onto dissolved oxygen to 
form H2O2 in solution (Gazaryan et a l, 2002).
The susceptibility of other Prxs to overoxidation has been reported previously 
(Yang et a l, 2002). The floodgate theory (Wood et a l, 2003) was used to explain 
the possible physiological reason for this. This theory proposes that at low H2O2 
concentrations, Prxs will play an anti-oxidant defence role in reducing H2O2 levels. 
However, when H2O2 concentrations are elevated sufficiently, the Prxs will tend to 
lose activity allowing H2O2 to act in a signalling capacity. The results from PrxIII 
also agree with this observation and are clearly shown by SDS-PAGE gel assay. 
Wood et a l (2003) also find that and the AhpC, a bacterial peroxiredoxin, is more 
than 100 times less susceptible to overoxidation than human Prx 1. Thus they have
concluded that bacterial peroxiredoxins only behave as antioxidants whereas their 
eukaryotic counterparts also regulate H2 0 2 -mediated signalling.
Until recently the overoxidation of Prxs was thought to be irreversible. However, 
Woo et a l (2003) showed that the sulphinic acid form of Prxl, produced during the 
exposure of cells to H2O2 , is rapidly reduced to the catalytically active thiol form. 
A protein called sulphiredoxin (Srx), which was first identified in yeast and 
conserved in higher eukaryotes, was found to be able to reduce cysteine-sulphinic 
acid in the yeast peroxiredoxin Tsai (Biteau et a l, 2003). The ability of eukaryote 
cells to repair the overoxidized protein suggests its function is subject to redox- 
mediated regulation.
The PrxIII pathway attains maximal activity at very low H2O2 concentrations 
(10|aM or lower) owing to its high affinity for this substrate. In these 
circumstances, it is impossible to measure the K„i of PrxIII for H2O2 owing to the 
rapid exhaustion of substrate. Unexpectedly, when testing for the susceptibility of 
the pathway inhibition at high H2O2 levels, a second peak of NADPH-dependent 
peroxiredoxin activity was detected, that was contributed by TRR2 only. It is not 
clear whether this TRR2 activity at lOmM-lM H2O2 has any physiological 
relevance. TRRl was also reported to have peroxidase activity with a K,» value at 
2.5mM for H2O2 (Zhong and Holmgren, 2000).
On GFC analysis, dissociation of the dodecamer in its oxidised form was found to 
occur at low protein concentration. Interestingly, the presence of the His-tag 
sequence affects the stability of PrxIII oligomerization. No previous studies have 
reported on the possible contribution of the N-terminal His-tag to the 
oligomerization of Prxs. Unfortunately, the N-terminal sequence was not ordered 
enough to see in the crystal structure, so how the N-terminal His-tag affects dimer- 
dimer interactions is unclear. However, as the His-tag can be cleaved off by 
thrombin, experiments can be performed in the presence or absence of the His-tag 
for comparison. Preliminary results (not shown) indicate no difference in 
peroxidase activity using the PrxIII pathway assay between the enzyme with or 
without its His-tag protein.
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The redox-state of PrxIII also acts like a switch of oligomerization. The oligomeric 
properties of this 2-Cys Prx have been studied using different methods. Factors 
such as ionic strength, pH, magnesium or calcium concentration have been shown 
to affect the oligomeric states of Prxs. Here, our results also showed that 
concentration affects oligomeric state of non-His-tagged protein in oxidised form. 
However, reduction of the active-site disulphide bond of typical 2-Cys Prxs is 
shown to be the primary factor governing the stability of the ring structures (Wood 
et a i, 2002). The exact relationship between peroxidase activity and oligomeric 
state is still unclear, but they appear to be closely linked.
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Chapter 5
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Solving the Structure of PrxIII
5.1 Results
5.1.1 Protein purification for crystallization
PrxIII was first purified by zinc metal chelate chromatography as described 
previously (Gourlay et a l, 2003). For the ciystallization study a further purification 
step was needed, therefore the zinc metal chelate chromatography was followed by 
an anion exchange POROS® HQ column with buffer exchanged into 50mM Tris- 
HCl pH 8.5 with an NaCl gradient (0-lM) used to elute the protein (Material and 
Methods section 2.4.7). Another buffer exchange was performed into 50mM NaCl, 
20mM HEPES pH 7.2, lOmM dithiothreitol (DTT) and 5mM EDTA followed by 
gel filtration chromatography with the purified protein used directly for 
crystallization.
5.1.2 Sitting drop vapour diffusion
■II'
All ciystallization trials were conducted using the sitting drop technique. Typically, 
crystallization reagent (1ml) was added to the reseiwoir and 2|al of purified protein 
solution was mixed with 2ql of reservoir solution on the platform of the trays. The 
ciystal trays were then sealed by Crystal Clean^ "^  tape and kept in the incubator at 
an appropriate temperatine for equilibration.
5.1.3 Crystallization screening
Crystallization trials were performed at different temperatures but mainly at 16°C. 
The initial crystal screening was canied out with Crystal Screen™, Crystal Screen 
2 TM (Hampton Research), Ciyo' '^^ I and II (Jena Bioscience) and Wizard™ Screens 
I and II (Emerald BioSystems). A protein concentration of 1 Omg/ml was used for 
the screen.
Needle crystals of wild type PrxIII appeared in 3 days from condition 5 (5% 
isopropanol, 2.0M (NH4)2 S0 4 ) of the Hampton crystal screen 2 (Fig 5.1). No other 
conditions gave diffracting protein ciystals.
Different cryoprotectant compounds such as MPD (m-phenylene diamine), PEG
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(polyethylene glycols) 400 and isopropanol were then tested. The mother 
liquor, with 25% glycerol added, gave no ice rings and the crystal diffracted to a 
similar resolution as crystals in a capillary. These crystals diffracted to 10Â 
resolution at beam line IDl 1, ESRF, Grenoble, France.
Figure 5.1 Needle crystals obtained from the initial screen
The condition is 5% isopropanol, 2.0M (NH4)2S0 4 .
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5.1.4 Crystallization and data collection of native Prxlll and its mutant
Many different conditions for crystal growth were screened such as protein 
concentration, (NH4)2S0 4  concentration, isopropanol concentration and 
temperature. Wild-type Prxlll crystals could only be optimised to diffract to 5Â 
resolution with a relatively small size while the Prxlll C168S mutant with His-tag 
gave larger crystals with better diffraction (Fig 5.2). The best crystals of Prxlll 
C168S, grown in the condition 5% isopropanol and 1.7M (NH4)2S0 4 , diffracted to 
3.3Â resolution at station 14.1, SRS, Daresbury, UK.
Figure 5.2 Optimized crystals of P rx lll C168S
The condition is 5% isopropanol 1.7M (NH4)2S0 4
After autoindexing the first image by MOSFLM (CCP4, 1994), spacegroup C2 was 
chosen as the best possible spacegroup with highest symmetry. A simple formula 
was used to estimate the maximum permitted rotation range to avoid overlap;
Aqp = 180d/jia - r\
where the factor 180/jr converts radians to degrees, r\ is the angular width of the 
reflection (mosaicity and beam divergence), d is the high-resolution limit and a is 
the length of the primitive unit-cell dimension along the direction of the X-ray 
beam (Wonacott, 1977). Due to the low-resolution data (3.3Â), relatively large 
mosaicity (0.8°) and relatively long axes (a=303.5 Â; c=122.3 Â), the oscillation 
angle is required to be between 0.1 to 0.8 degrees to prevent serious overlap of 
spots. However, as the crystals belong to the C2 spacegroup, 180 degree collection 
was required to give 100% completeness. The best crystals did not diffract strongly 
and 180 seconds exposure time at SRS, Daresbury for each frame was needed to 
give best diffraction. To account for all these factors, a long exposure time was 
needed to complete the dataset. Although ciystals were frozen to 100°K during the 
data collection, radiation damage still occurred, and also the time was limited at the 
synchrotron to complete the data collection. Adding up these factors, 0.5 degree of 
oscillation was used to minimise overlap of neighbouring lunes with most output.
Data were indexed by MOSFLM using three blocks of data 45 degrees apart (0, 45 
and 90). Each block contains 2 images. All together 863 reflections with I/sigma(I) 
> 20 were used for indexing. C2 was chosen for the highest symmetry with lowest 
penalty (Table 5.1). Data were processed to 3.47Â (using a 50% cut-off from 
Rmcrgc)- Details of the data collection and processing are summarized in Table 5.2.
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No. Penalty Latt a b e alpha beta gamma Possible spacegroups
10 176 mC 264.81 81.08 160.15 105.1 119.6 71.3 C2
9 174 mP 81.08 125.42 154.26 111.1 105.1 90.9 P2,P21
8 128 oC 125.42 288.37 81.08 7T6 90.9 92.9 C222, C2221
7 83 mP 125.42 81.08 154.26 105.1 111.1 90.9 P2, P21
6 82 ml 148.31 276.61 81.08 89.9 122.3 87.7 C2(transformed from 12)
5 52 ol 81.08 125.42 276.61 92.8 89.9 90.9 1222,1212121
4 49 mC 288.37 125.42 81.08 90.9 106.4 87.1 C2
3 7 mC 298.07 8L08 125A2 90.9 112.1 89J C2
2 4 aP 81.08 125.42 154.26 69.1 75.1 90.9 PI
Table 5.1 List of possible Lane groups
Indexing using 863 reflections with I/sigma(I) > 20, the possible Laue groups sorted on 
penalty index. The lower the PENALTY, the better. The chosen one is highlighted in blue.
Ï
Space group C2
Unit cell dimentions (A) a=303.5; b=79.1 ; c=122.3
p n  115.5
Resolution (A)* 35-3.47(3.54-3.47)
Total/unique observations 36651(10923)
Compieteness(%)* 96.3(98.2)
Multiplicity* 3.1 (3.1)
Rmerge(%)* 8.0(50.9)
Mean l/o(l)*___________________ 9.8(3.2)________________________________
’^ Parentheses refer to final resolution shell.
Table 5.2 Diffraction data statistics of native PrxIII C168S
The Matthews’ coefficient (Matthews, 1968) suggested between 10 (Vm=2.8 
A^/Da) and 12 (Vm=2.3 A^/Da) monomeric subunits in the crystal asymmetric unit. 
Since most (6 out of 8) known typical 2-Cys Frxs structures are decamers, a self­
rotation function from program MOLREP was calculated. The result showed no 
peaks at a 72-degree chi angle indicating there is no 5-fold symmetry in the crystal 
structure (Fig 5.3). However, there are 3 peaks at 60-degree chi angle indicating 
three 6-fold symmetiy axes and also there are 3 lines of 6 peaks indicating 2-fold 
symmetiy (Fig 5.4). In each line the peaks occur at an angle of 30 degree to each 
other and are all perpendicular to a 6-fold peak, which also coincident with a 2-fold 
peak. Taken together these facts suggest a dodecameric rather than a decameric 
structure.
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Figure 5.3 The self-rotation function of P rx lll C168S
The self-rotation function was calculated by the program MOLREP with data in the 
10-4 Â resolution range and an integration radius of 30 Â with chi angle at 180, 120, 
90 and 72 degrees.
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Figure 5.4 The self-rotation function of P rx lll C168S
The self-rotation function was calculated by the program MOLREP with data in the 
10-4 Â resolution range and an integration radius of 30 Â with chi angle at 180, 
120, 90 and 60 degrees.
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Thioredoxin peroxidase B (TPxB, PDB code Iqmv, (Schroder et a l, 2000)) was 
chosen as the search model for the molecular replacement strategy for its high 
sequence similarity with PrxIII (64% identity and 22% similarity, see Fig 5.5) and 
high resolution crystal structure (1.7Â). The molecular replacement programs 
MOLREP (CCP4, 1994), AMoRe (Navaza, 1994) and PHASER (Storoni et a l, 
2004) with the default parameters using TPxB monomer, dimer and decamer as the 
starting model were all tried without any successful solutions. For example, 
AMoRe was run by autoAMoRe mode using data in the 10-4.0Â resolution range 
with a rotation function search sphere set to 30Â. No solution stood out. Similar 
parameters were used to run a rotation function using a monomer as the search 
model and then all peaks were used to run a translation function independently. 
After the first monomer was located, the program was asked to add the second one 
and so on. However, after 3 or 4 monomers were added together, clashes were 
found between monomers. PHASER was run using data in the 20-4.0Â resolution 
range in an auto search which includes rotation, translation and packing. The
sequence identity was set to 65%. The solution had a very low Z-score indicating a 
failure to find the right solution. With the unsuccessful trial of molecular 
replacement, SeMet protein was prepared to determine the structure by MAD 
phasing.
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Figure 5.5 Sequence alignment between thioredoxin peroxidase B (PDB code 
Iqmv) and P rx lll
Identical residues are outlined in red. The secondary structural elements of TPxB 
are shown. Sequence alignment performed with ClustalW (Chenna et a i, 2003) 
and the figure generated with ESPript (Gouet et al., 1999)
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5.1.5 SeMet Prxlll C168S
Within each subunit there are 2 methionines out of a total of 220 amino acids. One 
methionine is at amino acid 95 and the other is in the vector N-terminal His-tag 
linker sequence (Fig 2.2).
SeMet Prxlll production is described in Material and Methods section 2.2.9. The 
SeMet protein purification employed the same protocol as native protein except all 
buffers were degassed to prevent selenium oxidation.
The best crystals of SeMet Prxlll C168S were obtained from 2 pi drops of protein 
solution (38 mg/ml) mixed with a 2 pi volume of a reservoir solution containing 
1.65 M ammonium sulphate and 5% isopropanol. These crystals grew to a size of 
0.5 X 0.2 X 0.2 mm in a week.
Fig 5.6 SeMet P rx lll C168S crystals
Growth condition was 1.65 M ammonium sulphate and 5% isopropanol
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5.1.6 Data collection
Mother liquor with 25% (v/v) glycerol was used as a cryoprotectant. X-ray 
diffraction data sets were collected at 100°K using synchrotron radiation (European 
Synchrotron Radiation Facility, Grenoble, France) at the BM14 beamline equipped 
with a MARMOSAIC225 CCD detector.
An energy scan (Fig 5.7) was performed to determine the wavelengths of peak and 
inflection point to give the maximum anomalous signal. The wavelength was set at 
0.9790Â for the peak, 0.9792 Â for the inflection and 0.9537 Â for the remote. A 
30s exposure time was used for each frame. In total 720 frames were recorded for 
the peak data with a crystal-detector distance of 325 mm and 0.5 degree of 
oscillation for each frame. Subsequently 360 frames were recorded for the 
inflection data with a crystal-detector distance of 325 mm and 0.5 degree of 
oscillation. Finally 360 frames were recorded for the remote data with a crystal- 
detector distance of 335 mm and 0.5 degree of oscillation with 30s exposure time.
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Figure 5.7 Energy scan of SeMet P rx lll C168S crystal
Data were indexed by MOSFLM using a similar strategy to that described in 
section 5.1.4. C2 was chosen for the highest symmetiy with lowest penalty.
All data were processed to a resolution of 3.3Â (using 50% cut-off from Rmcrgc) 
using the programs MOSFLM, SCALA and TRUNCATE from the CCP4 package 
(CCP4, 1994). Data collection statistics are summarized in Table 5.3. A subset of 
5% of reflections was used independently for the calculation of an Rfrce to assist 
decisions regarding refinement protocols.
The Matthews’ coefficient (Matthews, 1968) also suggested between 10 (Vm=2.8 
âVDu) and 12 (Vm=2.3 Â  D a )  monomeric subunits in the crystal asymmetric unit. 
The acentric moments statistics produced by SCALA (see Fig 5.8) showed no 
indication of ciystal twinning, a result similar to that obtained for the native data.
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A self-rotation function, calculated by the program MOLREP with data in the 10-4 
A  resolution range and an integration radius of 30 A  showed veiy similar results to 
the native data (see Fig 5.9).
Peak Inflection Remote
Wavelength(A) 0.9790 0.9792 0.9537
Resolution (A)* 35.8-3.3 35.8-3.3 30-3.3
Total/unique observations 314446/41825 157009/41830 156691/41665
Completeness(%) 99.9(100) 99.9(100) 99.9(100)
Multiplicity* 7.5(7.6) 3.8(3.8) 3.8(3.8)
RmciEc(%)* 12.2(50.7) 14.5(52.5) 13.9(62.7)
Mean I/a(I)* 15.9(2.2) 11.0(2.1) 12.0(2.8)
’‘Parentheses refer to final resolution shell.
Table 5.3 Diffraction data statistics relevant to the MAD experiment on 
SeMet P rx lll C168S.
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MOLREP
Self Rotation Function
RF(lhcla.i)lii.chi)_max : 2.775 mix : 0.1X61 Rad : 30.(M) Rcxinax ; 4.(X)
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Figure 5.9 The self-rotation function of SeMet P rx lll C l688
The self-rotation function was calculated by the program MOLREP with data in 
the 10-4 Â resolution range and an integration radius of 30 Â with chi angle at 
180, 120, 90 and 60 degrees.
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5.1.7 Locating the Se
Datasets of the inflection and remote wavelengths were processed using the same 
protocol as the peak wavelength dataset. Three wavelengths (peak, inflection and 
remote) data were merged into one datafile by CAD from the CCP4 package. The 
multiwavelength anomalous diffraction (MAD) methods were tried in order to 
locate the selenium atoms from the two methionine residues in each subunit. 
AutoSHARP (Fortelle and Bricogne, 1997; Vonrhein, 2005), Shake and Bake 
(Weeks, 1999), Solve-Resolve (Terwilliger and Berendzen, 1999) and Shelx 
(Schneider, 1997) all failed to locate the selenium atoms. For example, ShelxD was 
used to search for 24 Se atoms (12 molecules in the asymmetric unit, 2 Se atoms 
per molecule) using data in the 20-5Â resolution range, with minimum allowed 
distance between sites set to 3.5Â and tried for 20 cycles. After running, the 
program gave the message “No suitable Patterson vectors found”. Solve was used
to search data in the 10-4.5Â resolution range for 24 Se atoms in 2640 residues. 
The program was able to find 5 heavy atoms. However, Resolve couldn’t improve 
the electron density maps to make them interpretable. Similar failures were 
encountered with AutoSHARP and Shake and Bake. The reasons for failing to 
locate Se atoms could be due to either the quality of the data and/or lack of phasing 
power (one Se atom per 110 residues).
5.1.8 PHASER
Due to the failure to locate the selenium atoms from MAD data, the molecular
replacement approach was applied to the peak dataset. This again proved
unsuccessful using an automated version of MOLREP, AMoRe and PFIASER (see
section 5.1.4 for details). A less automated approach for searching for oligomer
structure in PHASER, which was discussed on the CCP4 bulletin board
(www.ccp4.ac.uk), was introduced. The approach suggests that for an oligomeric
structure, it is better to search for a monomer and use the solution file of the
.monomer to find other monomers. An initial solution set was obtained by PHASER 
(Storoni et a i, 2004) using a dimer of TPxB B (PDB ID Iqmv) as a model to 
search for only one dimer. Data from 20-4.0Â resolution were used. Applying the 
solution a new run of PHASER was employed to search for another two dimers and
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a solution locating a semi-circular, trimeric assembly of dimers was obtained (Fig 
5.10a). On searching for another hexamer, a second independent half ring was 
found (Fig 5.10b). The best Z-score for the Fast Rotation Function was 12.51 (the 
second best with 10.94 Z-score) and for the Fast Translation Function was 11.72 
(9.53 for the second best one). No clashes were found from the program after 
Packing and the log-likelihood gain was 783.23 (a relatively high score for 
PHASER) after refinement. Applying the crystallographic 2-fold symmetry along 
the b axis to these solutions gave two interlocked dodecameric ring structures.
Î
S 
I
a
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Figure 5.10 Phaser solution
a) The first semi-ring trimer dimer found by PHASER, b) The second half ring. 
Instead of forming a full ring, the second half ring is independent of the first ring. 
The view is from close to the b-axis. The figure was produced using the program 
PyMOL(Delano, 2002)
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Rwork/RfrQ0(%) 22.3/26.5R.m.s deviations
Bond lengths (A) 0.019
Bond angles (°) 1.76
Ramachandran plot (%)
Core region 89.0
Allowed 9.3
Generously allowed 1.7
Forbidden 0
iî
5.1.9 Model building and refinement
This structure was refined in ten cycles of rigid body refinement, with a 
dodecameric ring treated as 12 domains, using the program REFMAC5 
(Murshudov et a l, 1997). After correcting the model to the Prxlll sequence, 5 
rounds of restrained refinement with tight NCS restraints reduced Rwork from 0.400 ■Æto 0.299, Rfree fi'om 0.405 to 0.356 and increased FOM from 0.598 to 0.711. An 
averaged map was calculated to give a much better quality map for model building.
Individual residue refinements were interspersed with manual rebuilding using the
programs COOT (Emsley and Cowtan, 2004) and Quanta (Accelrys). The quality 
of the electron density allowed modelling of amino acid residues 2-163 (of 195) for 
each monomer. Nine water molecules were found per asymmetric unit. Several 
more rounds of restrained refinement with tight NCS restraints reduced Rwork to 
0.223, Rfree to 0.265 with good stereochemistiy (Table 5.4).
^Parentheses refer to final resolution shell.
Table 5.4 Refinement statistics of SeMet P rxlll C168S
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5.1.10 Self-rotation Function
The model produces an explanation for the self-rotation function data in Fig 5.9.
The two lines of six 2-fold peaks ((j)= 64, cp=+-150; c|)= 38, cp=+-130; (j)= 25, cp=+- 
75; ({)= 38, (p=+-23; (()= 64, cp=0) represent the 2-fold axes in the plane of the ring.
Because the ring was composed of six homodimers, there are 12 2-fold axes on the 
plane, which gives a 30 degree angle between adjacent axes. The two 2-fold peaks 
at (()= 66, cp=104 and (j>= 66, cp=-104, with coincident 3-fold (chi=120) and 6-fold 
(chi=60) axes, are the two 6-fold axes perpendicular to the planes of the rings.
These two 6-fold axes are perpendicular to the 2 lines of six 2-fold axes as well.
The large, apparently 6-fold, peak at (j)= 64, cp=0 is actually the tail of a peak 
arising from a improper rotation of 55 degree (Fig 5.11c) which is the angle
■between two planes of the rings (Fig 5.1 lb). In addition, another 2-fold peak at (j>=
26, (p=180 is an axis in the plane of the page and runs vertically through the centre 
of the model shown in Fig 5.1 lb. The two peaks at (|)= 90, qp=90 and cj)= 90, cp=~90 
are the crystallographic 2-fold symmetiy since the spacegroup is C2.
I
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Figure 5.11 Self-rotation function explaination
a) The self-rotation funetion caleulated by MOLREP. b) The side view of the 2- 
ring eatenane strueture. c) Same parameters as (a) but with chi angle at 55 
degrees.
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5.1.11 The anomalous signal contained contribution from the Se atoms
Although the MAD procedures failed to locate selenium atoms, applying the phases 
obtained from PHASER to the MAD data, anomalous peaks were found and 
located exactly at the positions of the Se atoms of the selenomethionine residues. 
Although some of the 12 anomalous peaks are weak, most of them are relatively 
strong (over 5 sigma).
a
Fig 5.12 Anomalous peaks
a) The electron density map at 4 sigma by applying the MR phase to MAD data 
showing the anomalous signal. The yellow circle indicates the 12 peaks in one 
ring, b) By comparing the model, all the anomalous signals are accurately 
located at Met95.
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5.2 Discussion
Wild-type Prxlll only yielded needle-like crystals that diffracted poorly with 
crystallization conditions containing 2M ammonium sulphate and 5% isopropanol. 
Better crystals were obtained from a C168S mutant around those conditions. The 
best crystals of Prxlll C168S were obtained from 1.7M ammonium sulphate and 
5% isopropanol and diffracted to 3.47Â resolution. However, no solution could be 
obtained by Molecular Replacement (MR) using different Prxs as search model in 
various MR programs. Therefore SeMet was introduced to solve the phase 
problem. Apart from overexpression, the SeMet protein behaved similarly to the 
wild-type enzyme. Similar crystals were obtained in the conditions as previously 
described. Higher concentrations of protein gave bigger and better crystals; 
therefore, veiy high (38 mg/ml) concentrations of protein were used to obtain large, 
well-ordered crystals with a diffraction to 3.3Â resolution.
Eventually PHASER revealed a solution that was completely unexpected. The 
3.3Â data enabled the main chain of the protein to be easily traced. In addition side 
chains within the areas of strong secondaiy structure were determined without any 
difficulties. However, the electron density in some mobile parts is very poor 
making it impossible to locate the position of the side chains. While the average 
map, comprising 12 subunits, gave a much better map overall, it did not improve 
much in some areas and the density map was so poor that no model could be built 
beyond residue 163. It is very unfortunate that the conserved C-terminal cysteine 
168 could not be located and therefore, valuable information about the active site is 
not available.
With tight NCS restraints and manual refinement, the Rwork dropped to 0.223 and 
Rfrcc to 0.265, which is very good at this resolution, with good stereochemistry 
(Table 5.4). The structure coordinates and stmcture factors have been deposited to 
the Protein Data Bank with ID IZYE. The stmcture will be discussed in the next 
chapter.
Although bias could have been introduced from the search model by molecular 
replacement, there are several pieces of evidence that support the model. Firstly,
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the R factor went down after refinement with good stereochemistry and no clashes 
were found with the model. Secondly, the anomalous signal contributed from Se 
atoms located exactly at the positions of the sulfur atoms of the methionine 
residues. Thirdly, analysis of the intensity distribution showed conclusively that it 
was not a twinned crystal. Finally, the independent program Self-rotation Function 
result matches the model perfectly with all the major peaks explained.
IJJ'
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Chapter 6
no
Structure Analysis
6.1 Introduction
The typical 2-Cys Prxs are the largest class of Prxs and are identified by the 
conservation of their two redox-active cysteines, the N-terminal peroxidatic 
cysteine (generally near residue 50) and the resolving C-terminal cysteine (near 
residue 170). All the typical 2-Cys Prxs show very similar monomer structures with 
a thioredoxin fold, consisting of a seven stranded (3-sheet with parallel and anti­
parallel alignments. The sheet is surrounded by four or five a-helices of varying 
length. Typical 2-Cys Prxs form stable homodimers with the two subunits arranged 
in a “head-to-tail” fashion. The dimer interface, which has an NCS 2-fold, is 
created mainly by the formation of an anti-parallel (3-sheet ((37 from each 
monomer), which produces a 14-stranded, twisted (3-sheet running through the 
centre of the dimer.
Crystal structures of 17 Prxs have been elucidated so far in a variety of redox and 
oligomeric states. Although the monomer or the dimer is the biological functional 
unit, most Prxs will further assemble into decameric rings (Wood et a l, 2003). 
There are two exceptions from Mycobacterium tuberculosis, one is a 1-Cys Prx 
with an octameric organisation (Li et al, 2005) and another is a typical 2-Cys Pix 
which has been shown to exist as a dodecamer (Guimaraes et a l, 2005). The 
oligomeric properties of 2-Cys Prxs have been studied using a variety of methods. 
Factors such as ionic strength, pH, magnesium or calcium concentration have been 
shown to affect the oligomeric states of Pixs. However, reduction of the active-site 
disulphide bond of typical 2-Cys Prxs is shown as the primary factor contributing 
to stabilization of the ring structures (Wood et a l, 2002) and our results (see 
chapter 4). The exact relationship between peroxidase activity and oligomeric state 
is still unclear, but they appear to be closely linked.
The dimerization interfaces of Prxs were described by Sarma et al (2005) as A-type 
and B-type interfaces. The first structure of a Prx, human Prx VI (Choi et al,
1998), which is a dimer in the crystal structure, has a (3-sheet-based interface. They 
called this the B-type interface (for p-sheet). In all the ciystal structures of typical
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2-Cys Prxs, apart from HBP23 (see table 1.1), the protein further assembles into a 
ring structure formed by a pentamer or hexamer of dimers. Recent studies on the 
structure of hybrid PrxV (Kim et a l, 2003) and E. coli Tpx (Choi et al., 2003) 
show they form a dimer with a different loop-based interface. Sarma et al (2003) 
call this the A-type interface (for alternate). The dimer-dimer interfaces in the 
decameric and dodecamer stmctures are also A-type interfaces, so the decamers 
and dodecamers are built up using both of these interfaces. In AhpC, it has been 
shown that it will dissociate into B-type dimers during the catalytic cycle (Wood et 
o l, 2002). Thus, B-type dimers only exist in the typical 2-Cys Prxs while the A- 
type interface is much more widespread. For these reasons, Sarma and co-workers 
hypothesized that the A-type dimerization interface preceded the B-type interface 
in evolution.
An overlay of the dimer interfaces of typical 2-Cys Prxs is shown in Fig 6.1. From 
this figure we can tell, apart from the MtAhpC (blue line), other typical 2-Cys Prxs 
share very similar structures (see section 6.2.1 for detail).
I
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Figure 6.1 The overlay of typical 2-Cys Prxs
All structures are overlaid to chain A o f TPxB (pdb Iqmv). Different subunits are 
shown by transparent cartoon in different colours. The interface between monomer A 
(yellow) and B (purple) is the B-type interfaee while the interface between A and C 
(green) is the A-type. The blue C a indicates MtAhpC. The B-type and A-type 
interfaces are highlighted. The figure was produced using the program 
PyMOL(Delano, 2002).
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compete with each other for the N-terminal Cys. This might explain the differences 
in sequence and structures.
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6.2 Results 
6.2.1 Monomer structure
Monomeric bovine PrxIII C168S is a compact globular structure, with the typical 
thioredoxin fold of the Prx family constmcted around a seven-stranded twisted 
mixed p-sheet, in the order (35-(34-p3-(36-|37, surrounded by five a-helices of 
varying length (Fig 6.2). One face of this central (3-sheet has two helices (a2 and 
a5) packed against it, with the other face being covered by helix a4  and a (3(3a 
stioicture from the N-terminal part of the protein, comprising a p-hairpin ((31-p2) 
and following helix (a l). Another helix a3, which joins strands p4 and p5, is on 
the periphery of the monomer where it participates in oligomerization.
The PrxIII monomer stroicture is very close to other typical 2-Cys Prxs except 
MtAhpC, which forms a dodecamer rather than a decamer in the crystal structure
(Fig 6.1). Firstly, MtAhpC has two additional helical structures between residues 
19 and 34. Secondly, a2  of PrxIII has a position shift compared to the helix 
equivalent to a2  in MtAhpC. There is no significant difference in the rest of the 
structure. This is very surprising because only PrxIII and MtAhpC form 
dodecamers. However, although MtAhpC is classed as a typical 2-Cys Prx, its 
catalytic mechanism is different from others. It has two C-terminal Cys which
i
Figure 6.2 Cartoon diagram of the PrxIII monomer
a) Secondary structural elements are labelled, and N and C termini are indicated.
b) as for a) after 90 degree rotation along the vertical axis, c) topology diagram of 
PrxIII monomer. The figure was produced using the program PyMOL(Delano, 
2002) and Topdraw (CCP4, 1994).
115
6.2.2 Dimer structure
Stable dimers are formed across a non-crystallographic 2-fold axis that extends the 
central (3-sheet and buries a total of 1772 of solvent accessible surface (886 
per monomer). The dimer interface, which is similar to that formed in other typical 
2-Cys Prx structures, is created mainly by the formation of an anti-parallel p-sheet 
by six mainchain hydrogen bonds involving His 136, Leu 137, Ser 138, Val 139, 
Asn 140 (Fig 6.3). A 14-stranded, twisted p-sheet running through the centre of the 
dimer was produced (Fig 6.4).
From the structure-based sequence alignment (Fig 6.5), it is clear that Prxs share 
very close secondary structure. PrxIII has a much higher sequence homology to 
decameric Prxs (63% to TPxB) than to the dodecamer Prx, MtAhpC (33%), 
although they have the same quatemaiy stmcture.
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Figure 6.3 Hydrogen bonds between a pair of anti-parallel p-sbeets on tbe 
P rx lll dimer interface.
Green and cyan present different subunits. Hydrogen bonds were drawn by 
dotted lines with the distances marked (Â). The figure was produced using the 
program PyMOL(Delano, 2002).
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Figure 6.4 Cartoon diagram of the P rx lll dimer
a) The dimer interface is created mainly by the formation o f an anti-parallel p-sheet. 
Cys 47 is highlighted as a blue ball. Cys 168 is close to the C-terminal o f the model 
(5 residues) but no model can be built due to poor electron density in this region, b) 
as for a) after 90 degree rotation along the horizontal axis. The figure was produced 
using the program PyMOL (Delano, 2002).
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Figure 6.5 Structure based sequence alignment of selected Prxs
Residues involved in secondary structure are indicated by coils (helices) and arrows 
(strands) above the sequences. Regions involved in the type A and B oligomeric 
interfaces are also indicated by A or B below the sequences.IPRX and IXCC are 1-Cys 
Prxs and the rest are 2-Cys Prxs. In 2-Cys Prxs, 1QQ2 is dimer, 1E2Y, lUUL, 1 YEP, 
1WEO are decamers. IZYE and 2BMX are dodecamers. IZYE (PrxIII) is shown in blue. 
See Table 1.1 for PDB ID details of individual Prxs.
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6.2.3 Dodecamer structure
The 6-fold NC S-related dimers are assembled into a dodecameric ring stmcture 
with outer and inner diameters of 150 and 70 Â respectively (c/130 and 60 Â for 
the decameric Prxs) (Fig 6,6a), The dimer-dimer interfaces within the ring are 
formed mainly by hydrophobic residues (Leu 41, Phe 43, Phe 45, Val 73, Phe 77, 
Leu 103, Leu 120) burying 635Â^ of solvent accessible surface per monomer (Fig 
6.7 and 6.8). A similar dodecameric ring structure has recently been reported for 
the crystal stmcture of MtAhpCcnes (Guimaraes et al., 2005) (Fig 6.6b). This, and 
our result, shows that 2-Cys Prxs oligomers are not restricted to forming decameric 
toroids.
The sequence alignment on the type A dimer interface of PrxIII (IZYE), HBP23 
(1QQ2), TPxB (IQMV) and MtAhpC (2BMX) are highly homologous (8 out of 18 
are identical, 9 are conservative substitutions indicating no significant difference 
between them (Fig 6.5 and Table 6.1).
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IZYE (12mer) 
This work
1QQ2 (dimer) 
HBP23
IQMV (lOmer) 
TPxB
2BMX (12mer) 
MtAhpC
41 L Conserved Conserved K
42 D Conseiwed Conserved Conserved
43 F Conserved Conserved Conserved
44 T Conseiwed Conserved Conserved
45 F Conserved Conserved 1
73 V Conserved Conserved Conserved
74 D Conserved Conserved Conserved
75 S Conserved Conserved Conserved
77 F Conserved Conserved Conserved
78 S S T A
81 A Conserved Conserved Q
103 L P V I
104 T K T K
105 K R R R
109 R Q E Q
118P E E D
119G Conserved Conserved Conseiwed
120 L I I V
:}?
I'Æ;
Table 6.1 Sequences alignment of the PrxIII residues involved in the A-type 
dimer interface against other Prxs.
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b)
Figure 6.6 The Prx dodecamer
a) Prxlll dodecamer shown as a cartoon diagram and colouring is added using atomic 
B-factors. High B-factor is red and low B-factor is blue. The figure was produced 
using the program PyMOL (Delano, 2002). b) Crystal structure of MtAhpCci76s. 
Taken from (Guimaraes et a i, 2005).
1 2 2
a)
h
b)
Figure 6.7 Cartoon diagram of the P rx lll dimer-dimer interaction
a) A-type interface characterized by mostly hydrophobic interactions across a non- 
crystallographic 2-fold axis. The interface is contributed mainly by a3 and the loop 
region, b) as for a) after 90 degree rotation along the horizontal axis showing the two 
dimers lie at 120 degrees to each other (compared to 108 degrees for the decamer) 
which will give a dodecamer in the whole ring structure. The figure was produced 
using the program PyMOL (Delano, 2002).
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a)
b)
Figure 6.8 Detail of P rx lll type A dimer interface
Different subunits of the structure are shown in different colours as a cartoon 
diagram, a) the hydrophobic residues involved in the type A dimer interface are 
shown in red stick, b) as for a) after 90 degree rotation along the vertical axis. 
The figure was produced using the program PyMOL (Delano, 2002).
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6.2.4 Catenane structure
The most surprising feature of the ciystal structure of PrxIII C168S is its presence 
as a 2-ring catenane comprising two interlocking dodecameric toroids (Fig 6.9a). 
The planes of the rings are not at right angles, but are inclined at an angle of 55 
degrees (Fig 6.9b), which allows a larger contact surface between the rings. This 
arrangement explains a large peak in the self-rotation function at chi = 55 degrees 
with a coincident 2-fold NCS axis (Fig 5.12). There are twelve areas of contact 
burying 5 0 6 7 of solvent accessible surface between the rings (Fig 6.10). These 
contacts arise from four NCS-related copies of three distinct interfaces. The 
prominent feature of the first contact area is Lys 88, which projects into a polar 
cavity at the dimer-dimer interface and forms a hydrogen bond with Thr 104 (Fig 
6.10b). The second contact area is stabilized by a pair of NCS two-fold related 
hydrogen bonds between Lys 12 and Tyr 10 (Figure 6.10d). The contacts in the 
third area are also polar (Figure 6.10c). A salt bridge is clearly formed between Arg 
109 and Glu 67, but other hydrogen bond contacts cannot be defined due to the 
resolution and accuracy of the structure.
The sequence alignment of the ring-ring interaction domain shows no significant 
difference between PrxIII and TPxB, while quite large differences exist between 
PrxIII and MtAhpC (Table 6.2). This may suggest that TPxB has the potential to 
form a catenane but due to its smaller ring size (lOmer, not 12mer), it may not be 
able to accommodate another polypeptide chain within its central cavity. One 
interesting point is, in the eiystal strueture of TPxB, the crystal packing shows that 
two decamer rings lie at 60 degrees to each other (Fig 6.11). There are several 
contacts between the two rings which also including the equivalent residue to Lys 
88 of PrxIII (Lys 92 in TPxB). This may suggest that there are similar contaets 
between dimers but the interaction or the orientation are slightly different which 
will determine the final quaternary structure.
For the MtAhpC, although the size of the ring is similar to PrxIII (12mer), the 
absence of necessary amino acids, such as Lys 88, to promote inter-toroid contacts 
may inhibit catenane formation.
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IZYE (catenane) 
This work
2BMX (12mer) 
MtAhpC
IQMV (lOmer) 
TPxB
Lys 88 none Conserved
T h r104 Lys Conserved
Tyr 10 Ala Ser
Lys 12 Gin Conserved
Glu 67 Gin Conserved
Arg 109 Gin Glu
Table 6.2 Sequence alignment of the residues invovled ring-ring interactions
1 2 6
a)
b)
Figure 6.9 Surface diagram of the catenane structure o f P rx lll C168S
a) The overall structure of the two interlocking rings. Shown in red and gold 
respectively; b) side view of the 2-ring catenane structure illustrating that the 
planes of the 2 rings lie at an angle of 55 degrees to each other. The figure 
was produced using the program PyMOL (Delano, 2002).
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T104
Figure 6.10 Sites of interaction between the two interlocked rings.
a) An overview of the 3 main sites of polar contact between the 2 interlocked 
dodecameric rings depicted in red and blue, respectively. These are each 
replicated 4 times in the overall structure; b-d) detailed representation of the 
polar contacts between the two rings; b) hydrogen bond between K88 and 
Thr 104 located in a polar cavity; c) salt bridge between E67 and R109; d) 2- 
fold related hydrogen bonds between K12 and Y 10. The figure was produced 
using the program PyMOL (Delano, 2002).
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a)
Figure 6.11 Surface diagram of the crystal packing of TPxB
a) The packing of two-ring structure of TPxB in the crystal. The two rings 
are showing in blue and green respectively, b) as for a) after 90 degree 
rotation along the vertical axis. The figure was produced using the program 
PyMOL (Delano, 2002).
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6.3 Discussion
Catenane, as a word to describe macrocyclic molecules which are held together 
only mechanically without the aid of a chemical bond, was mentioned by 
Willstatter in a seminar at Zürich a century ago (Sauvage and Dietrich-Buchecker, :3
1999). The existence of the first chemical catenane was confirmed by a mass 
spectrometry measured by Schill in 1967 (Schill, 1967). In the same year, catenated 
DNA molecules were observed in the mitochondria of HeLa cells and human 
leukaemic leucocytes (Clayton and Vinograd, 1967; Hudson and Vinograd, 1967).
Since then, catenated DNA has been found to be common in nature and has been 
diseovered in a number of diverse biological systems.
As proteins have limited flexibility in their polypeptide chains, it was thought to be f
■■■very difficult to form a knot or a catenated quartenary structure. However, although
very rare, they do exist. Besides the so called “pseudo-knots” where cysteine |
residues lie close enough to become cross linked to give extra stability to the fold I
(Tamaoki et a i, 1998), there are “topological” knot proteins such as acetohydroxy
acid isomeroreductase (PDB ID: lyve) with the backbone chain tangled together I
(Biou et a l, 1997; Taylor and Lin, 2003).
There are three previous examples of protein catenanes cited in the literature and 
two of them are rather specialised cases. One is a totally artificially-produced 
peptide catenane based on a small segment of a dimeric mutant of the p53tet 
protein generated in vitro using chemical techniques. Another one is a viral capsid 
assembly of 420 subunits where the subunits are topologically linked by covalent 
(isopeptide) bonds creating a form of protein ‘chain maif which is highly resistant 
to degradation. The third example is the crystal structure of RecR from 
Deinococcus radiodurans, which is involved in homologous recombinational DNA 
repair in procaryotes (Lee et a l, 2004) (PDB ID: IVDD). Four RecR monomers
.„;|l
form a ring-shaped tetramer of 222 symmetiy with a central hole of 30-35 Â 
diameter. In the crystal, two tetramers are concatenated (see Fig 6.12). PrxIII 
C168S represents another example of a classical, naturally-occurring, interlocked 
2-ring protein structure, a protein catenane.
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Figure 6.12 Crystal structure of Deinococcus radiodurans RecR octamer
Two tetramers (pink and cyan) are concatenated to form an octameric structure 
in the crystal. The figure was produced using the program PyMOL (Delano,
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Preliminaiy data from analytical ultracentrifugation (AUC) (data not shown) and 
EM (Fig 6.13) studies indicate that the PrxIII C168S preparations employed for 
crystallisation contain a mixed population of single and double-ring oligomers. The
protein concentration.
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oligomerization of the protein is concentration dependent. This was also reported in 
the other catenane structure (Lee et a l, 2004). A RecR tetramer (one ring) structure 
is found at 1 mg/ml and an octamer (two rings) stmcture is formed at 5mg/ml
We have no data indicating how the 2-ring catenane stmcture is formed but the 
crystal structure does provide some important insights into possible mechanisms of 
assembly (Fig 6.14). Dimeric units can interact in two different modes that are not 
mutually exclusive. One mode produces the dimer-dimer contacts, primarily 
hydrophobic, associated with ring generation in this and other Prx structures. The 
other mode gives polar contacts that could potentially initiate catenane formation at 
any stage during single toroid assembly by allowing two rings to form 
simultaneously around each other. A general model illustrating catenane formation 
arising from polar contacts between two basic dimeric units is described. At present 
it is unclear whether the fraction of the mixed population represented by the 
concatenated rings is assembled in vivo during overexpression in E. coli, or arises 
as a result of increasing protein concentration. A likely scenario is that interlocked 
double rings, single rings and a small population of dimers are in dynamic 
equilibrium in solution, so that during the ciystallisation process in vitro, where 
there is a very high concentration of protein, formation of crystals from the 
catenated rings would be the most favoured event.
Figure 6.13 Electron Micrograph of P rx lll C168S
Red circles highlight some of the protein catenanes. Picture was kindly taken 
and provided by Dr Bhella from IBLS, University of Glasgow.
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Figure 6.14 G eneral model for m echanism  of assem bly o f the 2-ring 
catenane structure.
Polar contacts between adjacent dimers (shown in red and gold), potentially 
occurring at any stage during single toroid formation, provide the basis for 
initiating the generation of a second topologically-linked ring leading to the 
overall 2-ring catenane structure. The figure was produced using the program 
PyMOL (Delano, 2002).
134
Chapter 7
135
Conclusions
7.1 Possible multiple functions of Prxs
1
The peroxiredoxins (Prxs) are a ubiquitous family of antioxidant enzymes that 
reduce hydrogen peroxide to water and were originally identified for their key role 
in antioxidant defence stemming fiom their peroxidase activity. However, in recent 
years, Prxs have also been implicated in regulating intracellular levels of H2O2 and 
are now considered to display multiple functions e.g. in limiting damage to ROS, in 
regulating HsOz-mediated signalling pathways (Wood et a i, 2003) and also more 
recently in serving as molecular chaperones under some conditions (Jang et a l, 
2004). Their vital contribution to antioxidant defence has been emphasised by their 
high abundance and ubiquitous distribution in both bacterial and mammalian cells. 
In the latter, they can account for 0.1-0.8% of total cellular protein (Chae et a l,
1999) and up to 5% of mitochondrial matrix protein (Chae et a l, 1994).
Prxs function as thioredoxin-dependent hydroperoxide reductases and typical 2- 
Cys enzymes, such as PrxIII, are organised as homodimers in which the adjacent 
subunits interact in a 'head-to-tail' fashion. During the catalytic cycle, the N- 
terminal cysteine is oxidised to a cysteine sulphenic acid by its peroxide substrate, 
which subsequently forms an inter-subunit disulphide bond with the conserved C- 
terminal cysteine of its partner. Atypical 2-Cys Prxs exist as monomers and 
generate an intramolecular disulphide bond during the reaction cycle (Seo et a l,
2000).
iThe peroxidatic cysteine (N-terminal cysteine) can be over-oxidised to yield inactive sulphinic (-SO2H) or sulphonic (-SO3H) acid forms. Studies of the 
susceptibility of eukaryotic Prxs to overoxidation and increasing evidence for their 
multiple roles has led to the development of the floodgate theory (as described in 
Chapter 1) that proposes a scheme for their involvement in cell signalling events. 
Wood et al. (Wood et a l, 2003) were the first to point out that bacterial 2-Cys Prxs 
are much less sensitive to oxidative inactivation than are eukaryotic 2-Cys Prxs. 
They concluded that this enhanced sensitivity of 2-Cys Prxs is not a limitation of 
the 2-Cys Prx eatalytic mechanism, but is a feature that has been selected for during
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Iithe evolution of eukaryotes. Thus, in eukaryotes, when H2O2 concentrations are low, Prxs will primarily act in an anti-oxidant capacity. However, when H2O2 
concentrations are elevated sufficiently, Prxs become temporarily inactivated and
y
H2O2 serves as a messenger inducing the expression of specific groups of genes 
required for the development of an appropriate stress response or ultimately 
activating the apoptotie pathway.
7.2 Overoxidation of PrxIII
As shown in this thesis, PrxIII is also susceptible to over oxidation and loses 
peroxidase activity at increased H2O2 levels in the range 50pM to ImM. From 
SDS-PAGE analysis of H202-mediated PrxIII oxidation, the appearance of 
abnormal oxidation states of PrxIII is also readily detectable at similar elevated 
levels of peroxide. Indeed, the Prxlll pathway reaches maximal activity at H2O2 
concentrations of 5pM or less suggesting that this enzyme operates most efficiently 
at substrate levels in the micromolar or submicromolar range.
7.3 PrxIII pathway
Bovine PrxIII was cloned previously in our laboratory (Gourlay et a l, 2003); 
however PrxIII requires its cognate partners, mammalian mitochondrial thioredoxin 
(Ti"x2) and mammalian mitochondrial thioredoxin reductase (TRR2), to reconstitute 
the complete anti oxidant defence system. To establish a direct in vitro assay for 
PrxIII, Trx2 and TRR2 were cloned, overexpressed and purified in this study. As 
TRR2 is a SeCys protein, a suitable SECIS for the translation of its penultimate 
SeCys codon was introduced by incorporating it into the reverse primer for PCR. A 
combination of different approaches was used for the successful overexpression of 
active TRR2. Overexpression in the modified rich LB media at 15°C in the 
presence of low IPTG concentrations gave good overexpression of soluble enzyme. 
Moreover, the addition of the SECIS at the C-terminal of the insert, in the presence 
of 1 pM Na2Se0 3  and co-expression of the SelABC plasmid ensured an optimal 
supply of the relevant tRNA, tRNA synthase and elongation factor for translation 
of the UGA SeCys codon. To develop the optimal conditions for determination of 
pathway activity, different concentrations of pathway components were varied 
independently in the reconstitution mix to achieve a situation where PrxIII levels
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were rate limiting to the overall reaction. A relatively high concentration of TRR2 
was required, presumably reflecting the low specific activity of the recombinant 
enzyme compared to its wild-type counterpart.
Assays showed that NADPH-linked oxidation needed the presence of all three 
enzymes to reduce H2O2 . PrxIII was also shown to reduce other organic peroxides, 
although with lower activities. Cys47 and Cys 168, but not Cys66, proved to be 
crucial for peroxiredoxin activity. Interestingly, at high H2O2 concentrations in the 
non-physiological range, TRR2 also had the capacity to reduce H2O2 directly in an 
NADPH-dependent manner. This property is also found in mammalian TRRl 
although it is not clear if this has any physiological relevance (Zhong and 
Holmgren, 2002).
7.4 Srx and Molecular Chaperone Function
Until recently the overoxidation of Prxs was thought to be irreversible. However, 
Woo et a l (2003) showed that the sulphinic acid form of Prxl, produced during the 
exposure of cells to H2O2 , is rapidly reconverted to the catalytically active thiol 
foim. A protein called sulphiredoxin (Srx), which was first identified in yeast and is 
conserved in higher eukaryotes, was found to be able to reduce cysteine-sulphinic 
acid in the yeast peroxiredoxin Tsai (Biteau et a l, 2003). This ability of eukaiyotic 
cells to repair overoxidized Prxs suggests that the function of this class of enzymes 
may be modulated by their oxidation state.
In this context, cytosolic Prxl and PrxII were found to be responsible for yeast 
survival after heat shock although the ability of cytosolic Prxl to protect cells 
lacking PrxI/II under these conditions is not exclusively due to its peroxidase 
aetivity (Jang et a l, 2004). These authors also report that heat shock and/or 
oxidative stress induces a structural change in Prxl which results in a functional 
switch from a peroxidase to a molecular chaperone in vitro. They have developed a 
new model taking into account these additional observations. At low ROS 
concentrations, Prxs are present mainly as the standard low molecular weight 
species i.e. dimers or decamers in the case of Prxl with normal peroxidase activity. 
However, when yeast was placed under extreme conditions like heat shock or
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oxidative stress, Prxl shifts to previously unrecognized high molecular weight 
state, the structure of which is not clear at present. In this model, overoxidation of 
Cys47 acts as a highly efficient "HzOi-sensor" and induces this structural change 
with the aid of the Trx system. The novel structural switch is associated with 
functional change and this Prx now exhibits chaperone-like activity, enhancing cell 
survival under stress conditions. After oxidative stress, the cys-sulphinic acid can 
be reduced to cys-thiol by Srx and the high molecular weight complex dissociates 
into decamers and/or dimers, thus restoring peroxidase activity.
Although not included in this study, it will be necessary in future to investigate 
possible chaperone-related functions of PrxIII and its ability to assemble into a 
high Mr super-chaperone complex.
7.5 PrxIII oligomerization
Gel filtration chromatography was used to determine under which conditions the 
PrxIII dodecamer would dissociate to dimers. The results show that redox state, 
protein concentration and the N-terminal His-tag all affect the oligomerization of 
PrxIII. Structural studies of other Prxs show that there is a conformational change 
at the active site from reduced form to oxidized form, and that part of this active 
site is involved in the dimer-dimer interaction. Since the dimer-dimer interaction is 
contributed mainly from hydrophobic interactions, it is not hard to understand that 
at low protein concentrations it will form dimers but a mixture of dimers and 
dodecamers when the concentration is high. Interestingly the presence or absence 
of the N-terminal His-tag appears to affect the dimer-dimer interaction also. In the 
PrxIII pathway assay, (preliminary data, not shown) both the presence or absence 
of the His-tag has no obvious affect on the ability of PrxIII to sustain overall 
NADPH-linked reduction of H2O2 . Recently, we have also constucted S78V, I and 
D mutants of PrxIII which all display altered oligomer stability so it will be of 
interest in future to test their ability to function as thioredoxin-dependent 
peroxidases and further examine the relationship between the dimer-dodecamer 
switch and the regulation or alteration of function. It should be noted that GFC is 
not a suitable technique for resolving the different higher Mr oligomeric state of 
Pi'xIII since they all have a similar hydrodynamic radius.
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7.6 Crystal structure of PrxIII
Crystal structures have now been reported for 3 atypical 2-Cys, 8  typical 2-Cys and 
4 1-Cys Prxs. In 5 of the typical 2-Cys stmctures, the basic dimeric unit is further 
assembled into decameric rings. In the remaining 2-Cys and 1-Cys Prxs, the 
structures are monomers or dimers, with three exceptions. Recently an octameric 
organisation has been reported for a 1-Cys Prx from Mycobacterium tuberculosis 
(Li et a l, 2005) and another 2-Cys Prx from the same organism has been shown to 
exist as a dodecamer (Guimaraes et a l, 2005). The third one is bovine Pi’xIII, the 
protein studied in this thesis, which also forms a dodecamer. As the basic 
functional unit of all Prxs is either a monomer or dimer, the precise relationship 
between peroxidase activity and the oligomeric state of these enzymes is unclear at 
present. Electron Microscopy (EM) studies (Gourlay et a l, 2003; Wood et a l,
2003) have shown that Pi’xIII exists as an oligomeric ring (previously thought to be 
decameric) enclosing a central cavity, although its overall dimensions are, in fact, 
slightly larger than other typical decameric Prx structures.
In this study, the PrxIII crystal structure was solved which further reveals that the 
toroid is composed of 12 (not 10) monomers with a 6(2,2) symmeti'y. Surprisingly, 
two PrxIII rings are mechanically interlocked in the crystal to form a protein 
catenane. Interestingly, the catenane form represents only a small proportion (3- 
5%) of the total PrxIII population, as observed by EM studies at dilute 
concentration (10-50pg/ml). Preliminai-y AUC data (not shown) suggest that 2-ring 
catenane formation is concentration dependent. Dimeric units can interact in two 
different modes that are not mutually exclusive. One mode produces the dimer- 
dimer contacts, primarily hydrophobic, associated with ring generation in this and 
other Prx structures. The other mode involve polar contaets that could potentially 
initiate catenane formation at any stage during single toroid assembly by allowing 
two rings to fonn simultaneously around each other. A general model illustrating 
catenane formation arising from polar contacts between two basic dimeric units is 
described. At present it is unclear whether the fraction of the mixed population 
represented by the concatenated rings is assembled in vivo during overexpression in 
E. coli, or arises as a result of increasing protein concentration. A likely scenario is
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that interlocked double rings, single rings and a small population of dimers are in 
dynamic equilibrium in solution, so that during the ciystallisation process in vitro, 
where there is a veiy high concentration of protein, fonriation of crystals from the 
catenated rings would be the most favoured event.
Whether the catenane form of Pi'xIII has any physiological function is not clear. 
The observation that Prxs can protect cells from heat shock in a peroxidase- 
independent process might provide new insights into possible novel functions. It 
should be noted that the Prx structure undergoes large conformational changes in 
the monomer during oxidation and reduction. The two catalytic cysteines are 
separated by approximately 13Â in the reduced state but form a disulphide bond in 
the oxidized enzyme. Thus, the reduced enzyme and the conserved cysteine 
mutants (eg the C168S mutant of PrxIII) that are incapable of disulphide bond 
formation are stmcturally equivalent to the overoxidised form. During catalysis, the 
stracture will transform rapidly between its oxidised and reduced states, a process 
that also involves transient generation of covalent links between adjacent 
monomers in the basic functional dimeric unit. However, there is increasing 
evidence to show that the conserved cysteines may play a role as hydrogen 
peroxide “sensors” in addition to their catalytic role. At elevated hydrogen 
peroxide levels, Prx will be overoxidised triggering assembly into high molecular 
weight complexes with altered functions. It is possible that the ability of Prxs to 
associate into oligomeric rings of various sizes, super chaperone complexes or even
catenane structures might be essential for activating these novel functional 
properties. In this connection, a screen for unknown candidate proteins which can 
interact with Prxs in their various oligomeric states might provide important clues 
as to the diversity of physiological roles attributable to this interesting family of 
antioxidant enzymes.
There are three previous examples of protein catenanes cited in the literature and 
two of them are rather specialised cases. One is a totally artificially-produced 
peptide catenane based on a small segment of a dimeric mutant of the p53tet 
protein generated in vitro using chemical techniques. The other one is a viral capsid 
assembly of 420 subunits where the subunits are topologically linked by covalent 
(isopeptide) bonds creating a form of protein ‘chain mail’ which is highly resistant
■i,
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Ito degradation. The third case is the crystal structure of RecR from Deinococcus radiodurans, which is involved in homologous recombinational DNA repair in 
procaryotes (PDB id: IVDD) and is also present as a protein catenane (Lee et a l,
2004). The stmctures of RecR and Pi'xIII C168S show that proteins are also able to 
form catenanes although these are extremely rare at present.
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Appendix 1 The Growth of PDB content
Growth in the number of structures deposited per year (blue) and total holdings 
of the PDB (red) are shown from the time that the PDB was founded. The 
numbers used for year 2006 are projected based on actual entries available at 
the time of writing this thesis. Adapted from http://www.rcsb.org/pdb.
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Appendix II Complexity o f structures in the PDB
This three-dimensional contour plot displays the PDB holdings with 5 or 
more chains in the asymmetric unit as a function o f time. The plot shows 
that there has been an increase in number o f structures with a higher 
number o f chains per asymmetric unit between 1989 and 2004. The 
colour bar on the right defines the number o f structures in each group. 
Taken from (Dutta and Berman, 2005)
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Appendix 111 Plasmid maps of pQE 30, 31 and 32 vectors
There is an N-terminal 6x His-tag sequence followed by the multiple cloning 
sites. The different sequences between the His-tag and multiple cloning sites are 
highlighted in red.
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Appendix IV Plasmid map of pET-14b
There is an N-terminal 6x His-tag sequence followed by a thrombin cleavage 
site, and the multiple cloning sites. The cloning/expression region is shown 
in the lower panel.
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